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 The increased white adipose tissue mass associated with obesity is the 
result of both hyperplasia and hypertrophy of adipocytes. While adipocyte 
development and transcriptional processes are well studied in vitro, regulation of 
in vivo genes (such as leptin), the identity of the adipocyte progenitor cells and 
the development of the adipose organ have not been defined in vivo.   
 In this thesis, firstly KLF4 was discovered to be an essential early 
regulator of adipogenesis. KLF4 together with Krox20 cooperatively 
transactivates C/EBPβ, suggesting that KLF4 and Krox20 are part of an 
immediate early transcriptional network.  This network is upregulated in a 
lipodystrophic animal model, encoding a dominant negative transgene against 
C/EBP factors, suggesting that these animals carry hyper-adipogenic residual fat 
pads, which provide a niche for transplantation experiments for identifying 
possible adipocyte progenitors. When injected into the residual fat pads of 
lipodystrophic mouse, indeed, a cell population, sorted from stromavascular 
fraction reconstitutes a functional white adipose tissue. Next, through a leptin-
luciferase animal model, where luciferase is expressed only in adipocytes (see 
below), the location and timing of embryonic adipose development were 
 
 
determined. Identification of the location and timing led the way to study gene 
regulation and morphology of the developing adipose tissue in embryos.   
 Leptin is an in vivo regulated adipocyte hormone, which is the afferent 
signal in a negative feedback loop controlling body weight and energy 
expenditure. Leptin is secreted in proportion to adipose tissue mass. This 
suggests the possibility that cellular lipid content is sensed and that a fuller 
understanding of the mechanisms of leptin production could lead to the 
delineation of a lipid sensing mechanism in fat cells and possibly other cell types. 
To discover this mechanism, we searched for the region/s in the leptin gene 
promoter that control the transcription of the leptin gene using a deletion series of 
BAC transgenic mouse lines that express luciferase under the control of 
overlapping leptin regulatory sequences. Cis elements that confer qualitative and 
quantitative control of the leptin gene are located between – 762B and +8kb 
relative to the transcription start site.  
 Since luciferase is driven by leptin regulatory sequences in leptin-
luciferase animals and leptin levels are highly correlated with the amount of body 
fat, luciferase expression can be used as a surrogate for studying changes in the 
amount of adipose tissue. To study the responses of adipocytes to changes in 
weight, leptin-luciferase animals were used to show that weight loss induced by 
fasting or leptin treatment results in the retention of lipid-depleted adipocytes in 
adipose depots. This work led to the identification of a cellular program that 
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  CHAPTER 1: 
          Introduction 
Obesity as a Global Health Problem 
The first law of thermodynamics basically states that a thermodynamic 
system can store or hold energy and this energy is conserved. The regulation of 
body weight also adheres this principle of thermodynamics. Body fat increases 
when energy intake is consistently greater than energy expenditure and 
decreases when energy intake is smaller than energy expenditure. Excess body 
fat and obesity are the result of sustained positive energy balance. In the last 20 
years, medical and public health interest in obesity has skyrocketed due to the 
increased prevalence of obesity in United States. Today, the obesity epidemic 
has spread from the US to Europe and is now emerging in middle and even low 
income countries. In the United States, this trend affects all ages, races and 
socio-economic groups (Kuczmarski et al., 1994b). 
Obesity is associated with many other health complications including 
diabetes mellitus, coronary heart disease, several forms of cancer, and sleep-
breathing disorders (Kopelman, 2000a, b) (Friedman, 2000). Because of the 
health and economic costs of obesity, the immediate need to understand why 
humans are gaining weight has increased in recent years. The global epidemic of 
obesity possibly results from a combination factors such as genetic factors, 
increased availability of high-calorie foods and decreased requirement for 
physical activity due to sedentary lifestyle in modern society. Obesity became so 
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common within the world's population that it is beginning to replace common 
problems such as infectious diseases and under-nutrition as the most significant 
contributor to ill health (Kopelman, 2000a). 
Obesity is defined as excessive accumulation of body fat.  Body fat is 
most simply estimated by 
using a formula that 
combines weight and 
height. Invented by a 
Belgian polymath, body 
mass index (BMI) is defined 
as the individual's body 
weight divided by the 
square of his/her height, 
producing a unit measure of 
kg/m
Definition of obesity 
2
World Health Organization classifies individuals with BMI more than 25 as 
overweight, more than 30 as obese and more than 40 as morbidly obese 
respectively (Figure 1) (Committee, 1995; WHO, 1997). It is important to note 
 (Dalton et al., 2003). 
The formula assumes that most variation in weight for people of the same height 
is due to fat mass. The assumption, for example, does not hold true for people 
with increased muscle size.  




that, owing to differences in body proportions, BMI may not correspond to the 
exact same degree of fatness among different people as indicated above. 
Despite the fact that it does not provide an accurate measure of percent body fat, 
BMI allows meaningful comparisons of weight status within and between 
populations and the identification of individuals at risk of morbidity and mortality.  
For this reason, BMI sets up a general index and is very useful for 
epidemiological studies.   Consistent with this, increased BMI has been found to 
be associated with the incidence of type II diabetes, CHD and hypertension 
(Willett et al., 1999). 
One other accepted measure for obesity is waist circumference which 
correlates with the risk for CHD such as hypertension or blood lipid levels  
(Dalton et al., 2003). The National, Heart, Lung and Blood Institute classifies a 
high risk of obesity if men have a waist circumference greater than 102 cm, and 
women have a waist circumference greater than 88 cm (Colman et al., 1995; 
Flegal, 2007). The choice of cut-off points on the waist circumference involves a 
trade-off between sensitivity and specificity similar to that for BMI.    
Obesity as an emerging health concern  
Obesity is becoming a major health concern in the United States and an 
increasing problem in the developing world. The most recent National Health and 
Nutrition Examination Survey (NHANES) indicates that 66% of adults in the US 
are either overweight or obese, (Ogden et al., 2006). Obese individuals made up 
32.2% of the American adult population as of 2004, compared to 12.8% in 1962 
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(Kuczmarski et al., 1994a; Kuczmarski et al., 1994b). Interestingly, this 
increasing trend manifests itself even more among children and adolescents. The 
prevalence of overweight/obese children in the United States more than doubled 
since 1970s (Troiano et al., 1995; Yanovski and Yanovski, 2002). 
Obesity is not only a problem of United States, but a common condition in 
almost every continent. In Europe, a very comprehensive study (MONICA) 
showed that on average, 15% of men and 22% of women were obese. More than 
half the adult population between 35 and 65 years of age in Europe were either 
overweight or obese (Silventoinen et al., 2004). 
 
Figure 2 Distribution of BMI in different age and sex categories (Adapted from Friedman, 
2000) 
Even though obesity is often viewed as a problem of rich and developed 
countries due to food availability, it is actually rapidly increasing even in the 
developing world (Taubes, 1998). In fact, it is estimated that the number of obese 
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people in the world is equivalent to those suffering from hunger. For instance, in 
Turkey, the overall prevalence rate of overweight was 25.0% and of obesity was 
19.4% as of 2003. The prevalence of overweight among women was 24.3% and 
obesity 24.6%; 25.9% of men were overweight, and 14.4% were obese (Hatemi 
et al., 2003). Incidence of  obesity has also plummeted in countries such as 
Japan, Korea, China, and Thailand , where being overweight has traditionally not 
been a concern due to the traditional lifestyle and food habits (Popkin, 1994).  
Obesity rates amongst Pacific Islanders are astonishingly high, with a prevalence 
of over 60% in certain populations, which has developed a lot of interest for 
researchers to identify possible genetic factors (Bonnen et al., 2006; Hodge et 
al., 1995; Shmulewitz et al., 2001). 
Obesity as a disorder is defined as a threshold. In this regard; small 
changes in average weight might have a different effect on its incidence. 
Incidence of obesity has increased from 23.3% to 30.9% in recent years (Figure 
2). On the other hand, the average weight of a typical American increased only 7 
to 10 pounds (Friedman, 2003). This suggests that a small increase in average 
BMI of a population such as US population can lead to marked increase in the 
number of obese individuals. It is thus important to consider obesity as a 
threshold when interpreting the statistics for prevalence of obesity epidemic 
(Friedman, 2003) (Figure 2). 
Causes of Obesity 
Recent evidence in clinical and basic research shed light on what could be 
causing the obesity epidemic. As for other diseases, it is plausible to think that 
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obesity is determined by combination of factors, both environmental and genetic.  
From a population genetics point of view, it is almost impossible that the genetic 
make-up has changed in the last century, which suggests that environmental 
alterations be the major determining factor. Consistent with this, obesity epidemic 
is occurring predominantly among humans and house pets (Kopelman, 2000a; 
Mason, 1970; Overgaauw and Kwant, 2008; Stuart, 2008). This observation itself 
implies that the shift of environment is the major cause of the recent epidemic. As 
will be discussed, one major theory suggests that increased food availability and 
shift to sedentary life styles with the development of technology can explain the 
increase in the incidence of obesity (Campbell, 2008; Levitan et al., 2006; Neel, 
1999a). 
Genetic factors are the major determinants of an individual’s reaction to 
his/her environment. As much as 80% of variability in BMI can be attributed to 
genetic factors (Stunkard et al., 1990). Furthermore, twin and adoption studies 
suggest that body weight is among the most genetically controlled traits (Maes et 
al., 1997). Correlation between monozygotic twins reared apart/together does not 
differ significantly (Maes et al., 1997).  In parallel, people sharing the same 
childhood do not necessarily show the same body weight. All these studies imply 
that genetic influences on BMI/body weight are substantial. Next sections will 
discuss the factors that affect obesity and possible evolutionary theories that 




Genetic contribution to Obesity 
The fact that body weight in adults tend to stay stable suggests that body 
weight is maintained by an inherent homeostatic circuit. When the food intake is 
restricted to maintain a lesser body weight, energy expenditure decreases to 
balance this alteration or when a person overfeeds himself/herself, energy 
expenditure increases for the same reason (Cohn and Joseph, 1962). This, itself 
suggests that body weight is regulated by inherent cues of the organism.  
Studies in humans using both adoption and twins have shown that body 
weight is highly heritable. A large study of more than 100.000 individuals found a 
BMI correlation of 0.70 in monozygotic twins, with a heritability of %50-90 (Maes 
et al., 1997). This heritability is comparable to traits regarded as highly heritable 
such as height and even greater than traits which were accepted to have genetic 
roots.   Furthermore, children can be predicted to be obese less than %10 
chance if both parents have a normal body weight, %50 if one parent is obese 
and 70% if both parents are obese (Stunkard et al., 1980a; Stunkard et al., 
1980b). In parallel, mouse studies show that genetically different mouse strains 
gain different weights upon high fat feeding. For example, exposure to high fat 
diet results weight gain but the degree of weight gain varies depending on the 
strain background.  Among the mouse strains, C57B6/J and AKR/J become 
obese on high fat diet, on the contrary to SWR/J and FVBN/J (Astrup et al., 1994; 
Prpic et al., 2002; West et al., 1994). 
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In order to compromise with the environmental and genetic factors, many 
researchers propose that susceptibility to obesity is under genetic control and 
environment/behavior 
determine the phenotypic 
expressivity of the 
susceptible genotype.  
Rare Mendelian single 
gene disorders also occur in 
obesity, which presents 
another indication of the 
genetic basis of obesity. An 
example of this type of abnormality is ob and db mutations. Recessive mutations 
in the ob and db genes cause a syndrome of extreme obesity and diabetes 
(Coleman, 1978). Mice having mutations at either of these loci weigh 2 to 3 times 
more the wild type littermates. An early parabiosis experiment by Coleman and 
colleagues found that ob/ob partners of db/db mice experienced rapid weight 
loss, ate little food, became hypoglycemic, and died within 26 days of parabiosis 
surgery (Coleman, 1978). Similar responses were reported for normal, lean mice 
parabiosed to db/db mice, and it was concluded that both lean and ob/ob mice 
had normal satiety centers that were responsive to a satiety factor produced by 
db/db mice. The similarity of the obesity syndromes observed in the ob/ob and 
db/db genotypes also led to the conclusion that the two different genes influenced 
the same satiety mechanism. These observations led to the fact that ob/ob mice 
Figure 3: Depiction of thrifty gene hypothesis 
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had a normal satiety center but were unable to produce the humoral satiety 
signal, whereas db/db mice produced the signal but had a defective satiety 
center.  This factor was later identified by our lab in 1994, which will be 
mentioned in the following sections of this thesis (Zhang et al., 1994).  
An evolutionary perspective of obesity: Environment vs Genetics 
Body weight is determined by environment and behavior.  As discussed 
above, body weight is kept in limits through homeostatic mechanisms.  In this 
regard, then comes the question why this balance mechanism did not work at 
least for humans during the obesity epidemic. Relevant observations from recent 
studies show that every other species on earth, fat metabolism is well regulated 
and that most wild animals are in fact very lean and that they remain lean even 
when adequate food is supplied unless there is an infectious disease causing 
obesity (Dhurandhar, 2001). The thrifty gene hypothesis proposed by geneticist 
James Neel gives an explanation to this fundamental problem (Figure 3) (Neel, 
1962) (Neel, 1999a, b). Obesity is quite common, and it is evident that it likely 
had a strong genetic basis. Neel proposed that obesity/diabetes genes 
historically were advantageous in ancient times where food was scarce, but they 
became detrimental in the modern world. These obesity genes, named as thrifty 
genes by Neel, are genes which enable individuals to efficiently collect and 
process food to deposit lipid during periods of food abundance in order to use in 
times of food scarcity which was possibly frequently happening in ancient times 
(Neel, 1962, 1999a, b)  (Figure 3). 
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According to the hypothesis, the 'thrifty' genotype was advantageous for 
hunter-gatherer populations, especially for women, because it would allow them 
to fatten more quickly during times of abundance (Neel, 1962). Fatter individuals 
carrying the thrifty genes would thus better survive times of food-scarcity. 
However, in modern societies with a constant abundance of food, this genotype 
prepares individuals for a famine that never comes. When you combine the 
current environment with the sedentary lifestyle of today, the result is widespread 
chronic obesity and related health problems like diabetes (Neel, 1999a, b). 
The central principle of the thrifty gene hypothesis that famines were 
common and severe enough to select for thrifty genes in ancient times has been 
challenged by several researchers. It was argued that many of the populations 
that later developed high rates of obesity/diabetes seemed to have no history of 
famine (Speakman, 2008). A common example is the Pacific Islanders whose 
tropical islands had plentiful vegetation and fish. 
Body weight is relatively stable over decades for many adults, implying 
that it is under strict control through life. In fact, one study shows that males, on 
average gains only 0.3-1kg per year, indicating that approximately 99.8% of the 
calories are spent (Weigle, 1994). This suggests that calorie intake is strictly 
One other significant problem for 
the 'thrifty gene' idea is that it predicts that modern hunter gatherers should get 
fat in the periods between famines,  which was not the case in African/Australian 
hunter-gatherers (Speakman, 2008). 
Energy Homeostasis and Body Mass Regulation  
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balanced with the energy expenditure, keeping the weight within a small range. 
Consistent with this notion, perturbations to the animal’s normal body weight 
cause a counter reaction by altering food intake and energy expenditure. 
Rodents who have gained weight through overfeeding, once ad libitum, decrease 
the food intake and increase energy expenditure until the weight is normalized 
(Cohn and Joseph, 1962). Conversely, mice that are food restricted, once ad 
libitum, increase the food intake until the weight is normalized (Rothwell et al., 
1982; Rothwell and Stock, 1982). Similar observations have also been made in 
both lean and obese humans. Obese individuals on strict diets, regain the lost 
weight in the long run (Drenick et al., 1977; Johnson and Drenick, 1977). All 
these studies suggest that there is a regulatory system that keeps body weight 
stable at a “set point” upon changes in food intake/energy expenditure.  
The system that changes food intake acts through hypothalamus based 
on many studies.  Firstly, many hypothalamic tumors are associated with obesity 
or cachexia (Bauer, 1954). Furthermore, bilateral lesions of VMH region of 
hypothalamus are associated with increases in fat tissue. These active lesions 
also cause hyperphagia, causing obesity (Powley and Keesey, 1970). These 
evidences suggest that body weight and energy balance in mammals is 
controlled by a negative feedback loop including central nervous system and 
peripheral organs. Lipostasis theory, first proposed  by Kennedy and colleagues, 
states that  metabolites/signals/humoral factors from adipose tissue inform the 
brain about the energy status of the body and any divergence from the 
hypothetical “set point” causes changes in calorie intake/expenditure, keeping 
12 
 
the body weight in limits (Kennedy, 1953). The possibility of a secreted factor 
was later shown to be true through parabiosis experiments as explained below.  
A circulating factor for Lipostasis 
ob (obese) and db (diabetes) animals have identical phenotypes on the 
same genetic background. They are hyperphagic, show decreased energy 
expenditure and develop early obesity accompanied with hyperinsulinemia, 
sterility and thermoregulatory defects. Since 
the metabolic profiles were identical, these 
two putative genes were suggested by 
Coleman to be genetically linked and 
postulated to be part of the same pathway 
(Coleman, 1978). 
The evidence to the link between db 
and ob gene came from parabiosis 
experiments (Figure 4). Parabiosis is a 
surgical procedure where two animals are 
joined through peritoneum and scapula 
creating a capillary graft between animals, 
hence allowing the direct exchange of 
blood.  Interestingly, when Coleman performed the parabiosis between an ob 
animal and a wild type, ob animal gained much less weight compared to ob 
animal parabiosed to another ob animal. This suggested the existence of a blood 
Figure 4: Parabiosis experiments 
performed by Coleman 
Parabiosis experiments performed by 
Coleman led to the discovery of leptin 




–borne factor that is absent in ob animals and present in wild types. When db 
animals are parabiosed to wt animals, Coleman did not see any change in db 
animals (Coleman, 1978). Conversely, wild type animals died of 
hypophagia/starvation in 50 days. Similarly, ob animals parabiosed to db animals 
became hypophagic, lost adipose stores and died of starvation as was the case 
for wild type animals.  
Based on the abovementioned experiments, Coleman postulated that ob 
animals were lacking a factor that was present in wild type animals; further db 
animals were resistant to this secreted factor.  Coleman reasoned that db gene 
product was the receptor for this humoral/secreted factor, which was negatively 
regulating body weight and missing in ob animals.  
Additional evidence came from studies where VMH-lesioned obese rats 
are parabiosed to normal rats. In this setting, normal rats became hyperphagic 
and lost weight (Hervey, 1959). All together the evidence suggests that there is a 
blood-borne humoral factor and a receptor which possibly is expressed in 
hypothalamus. 
Cloning of leptin and leptin receptor 
The circulating factor that was missing in ob animals was successfully 
cloned using a positional cloning strategy by Jeffrey Friedman and his 
colleagues. Ob gene was found to be expressed predominantly in white adipose 
tissue and to encode a 167 aa protein (Zhang et al., 1994).  Friedman and 
colleagues found that C57BL/6J ob/ob carries a nonsense mutation at codon 
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105. In ob/ob mouse, a transposon is inserted into the first intron and prevents 
mature ob RNA to be expressed.  
In 1995, the leptin receptor was identified biochemically and later shown to 
be a cytokine family receptor with broad expression by Tartaglia et al. (Tartaglia 
et al., 1995).  It was later shown that leptin receptor RNA was alternatively spliced 
and that only one of the splice variants, referred to as ObRb , was mutant in 
C57Bl/Ks db/db mice (Lee et al., 1996). Among the leptin receptors ObRb was 
highly enriched in the hypothalamus in precisely those nuclei that alter body 
weight when lesioned (See above) (Fei et al., 1997; Lee et al., 1996). This 
genetic evidence proved the Coleman hypothesis, that leptin acted on the 
hypothalamus to control food intake and body weight. In parallel with the 
evidence, injections or infusions of leptin reduce food intake and body weight of 
wild-type and ob mice but have no effect on db 
Leptin primarily acts on a set
mice (Campfield et al., 1995; 
Halaas et al., 1997) (Figure 5). 
Leptin action 
 of neural pathways in hypothalamus. 
Basically, it activates pathways that inhibit food intake and inhibits pathways that 
activate food intake (Figure 5). A significant part of leptin's actions seem to result 
from inhibition of neuropeptide Y/Agouti gene-related peptide (NPY/AGRP)–
expressing neurons in the arcuate nucleus, a region in hypothalamus. These 
neurons stimulate appetite. On the other hand, leptin was also shown to activate 
pro-opiomelanocortin (POMC) neurons that reduce appetite by activating the 
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MC4 receptor in other parts of the brain (Friedman, 1997). It is very likely that 
there are other neural pathways that account for the full effect of leptin treatment. 
The identification of these extra circuits would provide extra understanding for 
delineating the molecular 
mechanisms. It has recently 
become apparent that leptin 
signaling has important modulator 
effects on dopaminergic neurons. 
These neurons are possibly a part 
of reward pathways that provide 
inputs 
Leptin also acts on 
metabolism independently of its effect on body weight regulation. Leptin 
decreases glucose/ insulin levels in ob/ob mice independent of the weight loss as 
assessed by using very small doses (Pelleymounter et al., 1995). Some of the 
peripheral effects of leptin are still unknown if they are mediated directly on 
peripheral targets or through CNS. Leptin also increases sympathetic nerve 
activity in several peripheral tissues (Haynes et al., 1997). 
Regulation of leptin gene 
to the nucleus accumbens 
(Hommel et al., 2006). 
The leptin gene is expressed predominantly in the fat tissue (Birsoy et al., 
2008; Maffei et al., 1995a). Furthermore the expression is very highly correlated 
Figure 5: Leptin and Lipostasis 
Leptin is secreted by adipose tissue relative to the 
amount of lipid stored. It acts on hypothalamus 
and changes food intake and energy expenditure 




with the amount of fat mass as shown in many independent studies (Guo et al., 
2004; Lonnqvist et al., 1997; Maffei et al., 1995b; Skurk et al., 2007). Obese mice 
such as ob/ob and high fat-fed models have elevated leptin mRNA levels (Maffei 
et al., 1995a). Conversely, lipodystrophic/fasted animals have lower leptin mRNA 
levels (Reitman and Gavrilova, 2000). Of importance, differences in leptin mRNA 
levels, as assessed using in situ hybridization, show marked differences in the 
levels of leptin RNA/cell as fat cells get larger or smaller (Maffei et al., 1995a). 
This correlation holds true in comparisons of adipocytes in obese vs. lean 
adipose depots, adipose tissue in fed vs. fasted in animals, comparisons among 
different adipose depots that vary with respect to adipocyte cell size and finally 
comparisons of leptin expression in fat cells in vitro vs. in vivo.  The strong 
correlation between leptin gene expression and adipocyte size supports leptin's 
physiological role as a humoral signal of fat 
Previously, changes in membrane cholesterol concentration related to 
adipocyte
mass (Skurk et al., 2007).  
Leptin is regulated by many other metabolic cues. Glucocorticoids directly 
stimulate leptin synthesis in adipocytes (Murakami et al., 1995). Leptin synthesis 
is also increased by infection/ endotoxins and cytokines such as TNF and and 
interleukin 1 (IL-1) (Bornstein et al., 1998; Sarraf et al., 1997). Conversely, 
administration of thyroid hormone decreases leptin levels in rodents (Escobar-
Morreale et al., 1997).    
 size have been proposed as regulators of gene expression in 
adipocytes. However, manipulation of cholesterol concentrations in 3T3-L1 
adipocytes does not alter leptin gene expression but does change expression 
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patterns of several other genes, including TNF-alpha (Le Lay et al., 2001). Thus, 
the mechanism underlying the strong correlation between leptin gene expression 
and adipocyte volume are unknown and identification of the transcriptional 
mechanisms that regulate leptin could shed light on these questions. 
While several prior reports have identified leptin promoter elements that 
respond to secretagogues such as insulin, glucocorticoids, endotoxins and 
thiazolidinediones,(Kolaczynski et al., 1996; Nolan et al., 1996; Zhang et al., 
1996) the factors that confer fat specific expression of the leptin gene and that 
regulate its expression in parallel with changes in fat mass are not known.   
Specifically, it is not known which trans-acting factors are responsible for the 
induction or repression of leptin gene expression.  Studies of the mouse, rat and 
human leptin promoter are limited, but have identified C/EBP alpha, Sp1, and 
Lp1 as playing roles in the regulation of leptin (de la Brousse et al., 1996; He et 
al., 1995; Hwang et al., 1996; Isse et al., 1995; Mason et al., 1998). These 
studies have all largely been done using leptin promoter constructs transfected 
into cell lines. However, leptin expression is ~100 times lower in in vitro 
differentiated adipocyte cell lines compared to tissue levels (Mandrup et al., 
1997a). Surprisingly, these adipocyte cell lines abundantly express the master 
regulator PPARƔ, C/EBPβ, delta and alpha and their targets. Furthermore, these 
transcription factors are also expressed in vivo in adipose tissue. This supports 
that the adipocyte-specific expression of leptin is controlled by a different 
transcriptional mechanism than the conventional adipocyte regulators  (Soukas 
et al., 2001b).  
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Although the abovementioned experiments have shed light into some of 
the trans-acting factors which can affect the transcription of a reporter gene 
attached to leptin promoter in vitro, whether these factors regulate leptin gene 
expression in-vivo is not established.  
Fat tissue biology 
Fat tissue was long believed to be an inert depot for the storage of energy. 
This view was upended in 1994 by the discovery of the hormone leptin, which is 
secreted by adipocytes and signals to the brain to control body weight (Zhang et 
al., 1994).  The intervening 15 years 
have led to the discovery of a 
complex cross-talk between adipose 
tissue and other organs that 
regulate metabolism and body 
weight (Farmer, 2006b). 
Nonetheless, our understanding of 
the biology of fat itself remains 
limited.  Understanding how adipose 
tissue mass is generated and 
regulated in vivo has major 
implications for the treatment of 
obesity and metabolic diseases. 
Figure 6: Adipose tissue is composed of 
different cell types 
This figure shows the adipose tissue whole mount 
microscopy from transgenic animals expressing 
GFP only in adipocyte nuclei. Red shows the 
capillaries. Note the GFP- DAPI+ stained nuclei, 
which represents the non-adipocyte cells. 
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Adipose tissue is a complex and essential endocrine/energy-storing organ. 
Besides adipocytes, adipose tissue contains connective tissue matrix, nerve 
tissue, stromovascular cells, and immune cells (Rosen and MacDougald, 2006)  
(Figure 6). Together, these components function as an integrated unit. Adipose 
tissue not only responds to afferent signals from CNS and other systems but also 
expresses a wide variety of peptides, known as adipokines, which function at 
both the local (autocrine/paracrine) and systemic (endocrine) level. Up to this 
date many secreted factors are discovered, including leptin, resistin, 
plasminogen activator inhibitor-1, and adiponectin. Through this interactive 
crosstalk, adipose tissue is involved in many biological processes including 
energy metabolism, immune function and neuroendocrine function.  
Fat is an integral organ to the whole organism. As with other essential 
organs, excess amount (obesity) as well as lack of it (lipodystrophy) cause 
adverse metabolic consequences. Excess adipose tissue, obesity, is associated 
with hyperglycemia, insulin resistance, dyslipidemia, hypertension, and 
inflammatory states (Kopelman, 2000a). Conversely, adipose tissue deficiency or 
lipodystrophy is also associated with features 
In mammals there are different fat depots, having different roles (Kissebah 
and Krakower, 1994). The main fat organs are subcutaneous and visceral 
adipose depots. These depots are responsive to energy stores and many 
hormonal/metabolic changes in an organism. There are also structural fat depots 
that can be found in many other areas, including in the retro-orbital space, on the 
of the metabolic syndrome in both 
humans and rodents (Gesta et al., 2007) (Hegele, 2000). 
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face and extremities, around breasts/thighs and within the bone marrow. Many of 
these areas are not responsive to energy level of the body. In addition, some 
adipose organs are responsive to sex hormones, such as adipose tissue in the 
breasts and thighs, whereas other depots, such as scapular fat, are responsive 
to glucocorticoids (Gesta et al., 2007).  The evolution of the complexity of 
different depots possibly emerged with the endothermic animals, where there is a 
need of energy for strict thermoregulation (Gesta et al., 2007). Next section 
discusses the evolution of fat depots. 
 
Figure 7 : Evolution of fat tissue 
Fat tissue distribution has changed in the course of evolution. (Gesta et al., 2007) 
Evolution of Adipose Tissue 
Almost all species, from simple invertebrates to Homo sapiens store their 
excess energy in the form of lipids (Figure 7). However, the cell type that stores 
the lipid differs from organism to organism relative to the complexity. For 
instance, C. elegans store fat in intestinal epithelium and sharks store fat in the 
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hepatocytes (McKay et al., 2003; Van Vleet et al., 1984). With the evolution of 
vertebrates, a special organ for storing fat appears- the adipose.  
Adipose tissue distribution and fat storage changed dramatically with the 
process of evolution. As explained above, even small invertebrates such as 
worms and flies store lipids at some point in their life cycles; however adipose 
tissue evolved with the emergence of boney fish, teleostei. Of note, intra-
abdominal white adipose tissue co-evolved with the adipocyte hormone- leptin- in 
boney fish (Figure 7). With the emergence of endothermic animals, differentiation 
of subcutaneous and internal WAT occured in higher species, such as birds and 
mammals. This further complexity possibly started due to the need to strictly 
stabilize the body temperature in endothermic animals. It is important to note that 
even though leptin seems to have coevolved with the adipose organ, adipose 
tissue is not the only organ to express leptin in the exothermic vertebrates (Gesta 
et al., 2007). Furthermore, there is very little evidence that leptin affects these 
exothermic animals the same way as it does mammals. Leptin, in exothermic 
animals such as frogs, fish and several reptiles, has been found to act on other 
functions such as the metamorphosis and development of these animals 
(Gorissen et al., 2009; Huising et al., 2006). This evidence suggests that the role 
of leptin as the signal for energy stores might have evolved with endothermia. 
Adipogenesis 
Adipogenesis is defined as the differentiation of adipocytes, which are 
committed for adipogenic lineage, into mature adipocytes (Rosen and 
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MacDougald, 2006; Rosen and Spiegelman, 2006). During the last 20 years, with 
the availability of adipogenic cell lines, a great deal of new information was 
learned about adipogenesis and transcriptional events regulating adipocyte 
differentiation (adipogenesis). Although many cell types may contain lipids, the 
unique property of adipocytes is that they can store a much greater volume of 
lipids, and further can release of these calories for use by other organs. For this 
reason, studying adipocyte differentiation specifically has clinical value to 
understand several metabolic diseases including obesity and lipodystrophy. 
Adipocytes are possibly differentiated through 2 phases. The first phase is 
the commitment of a pluripotent stem cell to the adipocyte lineage, also known as 
the determination step (Rangwala and Lazar, 2000). After the determination, 
stem cell loses the potential to differentiate into other cell types and committed to 
adipocyte lineage. In the second phase, which is known as terminal 
differentiation, the pre-adipocyte takes characteristics of the mature adipocyte. 
The molecular regulation of differentiation is more extensively studied than 
determination because most studies make use of adipogenic cell lines that have 
a restricted potential to differentiate into other cell types (Rangwala and Lazar, 
2000). 
Predetermination type of the above-mentioned in vitro model systems 
include the NIH-3T3 and the C3H10T1/2 cell lines, which are supposedly 
pluripotent and can therefore be differentiated into many different lineages such 
as adipocytes, osteocytes, or chondrocytes (Rosen and MacDougald, 2006). 
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 Other cell line models, such as the 3T3-L1 and 3T3-F442A are already 
committed to the adipogenic pathway, therefore considered to be preadipocytes 
(Green and Meuth, 1975). These cell lines were originally established by Green 
and colleagues, which have greatly facilitated our knowledge of the molecular 
mechanisms controlling adipogenesis (Green and Meuth, 1975). Confluent 3T3-
L1 preadipocytes are differentiated upon exposure to the adipogenic inducers 
fetal bovine serum (FBS), dexamethasone, isobutylmethylxanthine, and insulin. 
3T3-L1 preadipocytes differentiate into adipocyte through three steps. First, the 
cells go through a growth arrest at confluence, which is required for the initiation 
of differentiation events. Secondly, after addition of the hormone cocktail, cells 
synchronously enter into S phase of the cell cycle, through one or two rounds of 
mitosis, a step also known as clonal expansion. Finally PPARƔ, C/EBPα, and 
many of the adipocyte markers are expressed and the cells get their 
characteristic rounded morphology and accumulate lipid droplets, also known as 
terminal differentiation (Rangwala and Lazar, 2000). 
The validity of the 3T3 preadipocyte system as an appropriate model of 
adipocyte formation has been accepted by many researchers due to the similarity 
of genes expressed in vitro vs in vivo adipocytes. Furthermore, injection of 3T3-
F442A preadipocytes into mice gives rise to normal fat pads (Mandrup et al., 
1997a).  Despite this knowledge, the lack of a robust in vivo adipogenesis model 
hinders the comparison. The preadipocyte cells and in vivo characteristics of the 
cell types are unknown. 
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Molecular processes involved in adipogenesis 
Differentiation of preadipocytes into adipocytes is regulated by a complex 
and temporally regulated network of transcription factors that coordinate 
expression of hundreds of proteins responsible for establishing the mature fat-
cell phenotype (Figure 8). To this date, two principal adipogenic factors, PPARƔ 
and C/EBPβ, are thought to be the late and early master regulator of the 
adipogenic process respectively (Lefterova and Lazar, 2009). PPARƔ especially 
is considered the master regulator of adipogenesis, because 
precursor/preadipocyte cells are incapable of expressing any known property of 
the fat cell phenotype without PPARƔ (Tontonoz et al., 1994a; Tontonoz et al., 
1994b; Tontonoz et al., 1994c; Tontonoz et al., 1994d). 
Much of our knowledge of the adipogenic network and the importance of 
PPARƔ and C/EBPβ come from studies performed in established preadipocyte 
cell lines as discussed previously. Even though animal data for these two genes 
gave several indications of their role, (Jones et al., 2005b; Tanaka et al., 1997) it 
is especially hard to knock out these genes at the right temporal point due to the 
lack of the early markers and some of the genes such as C/EBPs have other 
roles in other cell types and development, causing embryonic/ postembryonic 
abnormalities when knocked out (Bai et al., 2006). 
The late master regulator PPARƔ was discovered by Bruce Spiegelman 
and colleagues by studying the regulators of aP2 gene (Graves et al., 1992; 
Tontonoz et al., 1994a). Spiegelman group identified an enhancer fragment that 
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regulates aP2 expression and consequently isolated the factor from adipose 
extracts using this fragment. This factor turned out to be PPARƔ, which is 
expressed in a fairly fat specific fashion. PPARƔ is expressed in two forms, 
namely g1 and g2. Among these forms, g2 is found selectively in adipose tissue, 
whereas g1 is found also in other tissues. PPARƔ is a nuclear receptor and like 
other PPARs heterodimerize with RXR and activates its target promoters 
(Mueller et al., 2002). Strong activation of PPARƔ requires the binding of an 
unknown endogenous agonist. When overexpressed, PPARƔ is sufficient to drive 
adipogenesis and no factor has been discovered promoting adipogenesis in the 
absence of PPARƔ.  In vivo, inducible knockout of PPARƔ
Among the early factors C/EBPβ seems to be indispensible for 
adipogenesis in immortalized pre-adipocyte lines (Hamm et al., 2001; Tang et al., 
2004). C/EBPβ-deficient mice have reduced adiposity (Tanaka et al., 1997). 
C/EBPβ promotes adipogenesis at least in part by inducing C/EBPα and PPARƔ 
 in differentiated 
adipocytes leads to adipocyte death followed by generation of new adipocytes 
(Jones et al., 2005b). This suggests that PPARƔ is also important for 
maintenance of the differentiated adipocyte state (Tontonoz et al., 1994d). 
Several C/EBP family members, including CEBPa, C/EBPβ and C/EBPδ 
were also shown to be crucial for adipogenesis (Figure 8). The temporal 
expression of these factors during adipocyte differentiation indicates a cascade 
where early induction of C/EBPβ and C/EBPδ leads to induction of C/EBPα and 
PPARƔ (Lefterova and Lazar, 2009). 
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(Zhang et al., 2004b). Consistent with this, C/EBPβ- deficient MEFs do not 
express C/EBPα and PPARƔ.  
 
Figure 8: Transcriptional Regulation of Adipogenesis 
Adipogenesis occurs through expression of a complex and temporally regulated transcriptional 
network. Adapted from Rosen, 2006 
Apart from C/EBPs and PPARƔ, there are other factors that are known to 
be involved in adipogenesis. Among these, KLF factors seem to have variety of 
roles. The range of KLF genes that are expressed in adipose tissue, the 
variability in their expression patterns during adipocyte differentiation, and their 
effects on adipocyte development and gene expression indicate that a cascade 
of KLFs function during adipogenesis (Rosen and MacDougald, 2006). Another 
recent study has characterized expression changes in all nuclear-receptor family 
members in 3T3-L1 adipogenesis (Fu et al., 2005). Several members of this 
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family, including the glucocorticoid receptor, are known to affect adipogenesis, 
but this study indicates that many others could potentially regulate this process.  
GATA-binding transcription factors GATA-2 and GATA-3 also play a critical role 
in the molecular control of the preadipocyte-adipocyte transition (Tong et al., 
2000). GATA-2 and GATA-3 are expressed in white preadipocytes, and their 
mRNAs are downregulated during adipocyte differentiation. One other 
transcription factor, CREB, is constitutively expressed prior to and during 
adipogenesis (Zhang et al., 2004a). Overexpression of a constitutively active 
CREB in 3T3-L1 preadipocytes is necessary and sufficient to initiate 
adipogenesis, whereas overexpression of a dominant-negative CREB alone 
inhibits adipogenesis. CREB phosphorylation, an event necessary for 
adipogenesis, is possibly among the earliest modifications in adipocyte 
differentiation upon hormone induction at least in vitro (Reusch et al., 2000b; 
Zhang et al., 2004a). 
During the terminal phase of differentiation, activation of the transcriptional 
cascade leads to increased activity, protein, and mRNA levels for enzymes 
involved in triacylglycerol synthesis and degradation. Along with the lipid 
accumulation, synthesis of adipocyte-secreted products including FABP4,  
adipsin, resistin, and adipocyte-complement-related protein (Acrp30) begin, 
producing a highly specialized endocrine/energy-storing cell that will play key 




Adipose tissue development in vivo 
Up to this date, origins of adipose tissue in terms of its location and 
possible progenitor cell types have not been fully characterized and precise 
lineage tracing studies have not been performed. Even though adipose is 
generally accepted as having a mesodermal origin, this theory has not been 
tested or studied and is based on the fact that fibroblastic cell lines and MEF 
cells can differentiate into adipocytes in vitro (Rosen and MacDougald, 2006). 
White adipose tissue can hardly be detected 
macroscopically/microscopically during embryonic life and at birth in rodents (rat, 
mouse) due to the lack of cell markers and lack of lipid accumulation. The 
development of white adipose tissue has been studied extensively in pig fetuses 
in early 1980s (Hausman et al., 1981). These studies show that approximately 
the beginning of the second third of the gestation period in pigs, an extensive 
vasculature and developing fat cell clusters can be observed, which are 
surrounded by extensive stroma (Ashwell et al., 1987; Hausman, 1985; Hausman 
et al., 1981; Hausman et al., 1984; Hausman and Thomas, 1984). The embryonic 
development of human adipose tissue takes place earlier than that of the pig in 
various sites (Fritsch and Kuhnel, 1992; Labbe et al., 1989). 
Based on the above-mentioned studies, adipose tissue appears and 
develops in the areas where it remains after birth. Initially, a dense mass of 
mesenchymal cells with no lipid accumulation occurs. Vascularization and 
accumulation of lipid possibly follows this process.  Interestingly, after the 
development of fluorescent markers and microscopic analysis, there is almost no 
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study on the development of adipose tissue up to this date. The idea that 
developmental and patterning genes might play a role in the differential 
development of various adipose tissue depots has been suggested by several 
recent studies (Vohl et al., 2004) (Gesta et al., 2006). These studies show that 
several patterning genes mainly from Hox families might have roles in in vivo 
adipose development. 
The adipose organ is composed of cells with different functions that most 
likely arise from different developmental lineages. Although the field of adipocyte 
biology has made great progress in vitro, we still lack markers capable of 
distinguishing preadipocytes that can define various stages in the differentiation 
process in vivo. Specifically, cell types, markers, morphology and anatomic 
location of these cell types before and after the determination step are not 
known. Identification characterization of these different cell types could provide 
new treatments for obesity and its complications. Even though it is widely 
controversial, some groups suggest that these preadipocytes might derive from 
blood lineage (Crossno et al., 2006). The defining experiments including a FACS 
sorting and characterization of different preadipocyte lineage from adipose tissue 
are lacking. 
  Regarding the preadipocyte markers, the only widely accepted marker of 
preadipocytes is preadipocyte factor 1 (Pref-1; also known as DLK-1 or 
Drosophila Homolog-like 1) (Villena et al., 2002). Pref-1 is expressed at high 
levels in both white and brown preadipocytes, and expression markedly 
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decreases upon differentiation. Pref-1, however, is not unique to the 
preadipocyte and is also expressed in other tissues such as placenta, pituitary, 
adrenal cortex, fetal liver and pancreatic islet cells. Pref-1 is synthesized as a 
transmembrane protein and is cleaved to generate a soluble form that acts to 
inhibit adipocyte differentiation. Mice lacking Pref-1 show accelerated fat 
deposition, (Moon et al., 2002). Despite this, it is not known what type of 
preadipogenic cell types express Pref-1. 
Adipogenesis and Diseases 
The increase in adiposity in obese individuals may result from an increase 
in both adipocyte number and size of individual fat cells (Rosen and 
MacDougald, 2006). Disproportionate increase in the visceral adipose depots in 
some individuals is thought to be linked to development of certain metabolic 
disorders. Understanding the mechanisms regulating fat tissue formation should 
have implications for treatment of obesity. 
 It is generally regarded in clinical medicine that adipocyte number of a 
person is determined just after birth and stays constant through life. This notion 
however is not based on any experimentation. In fact, several rodent models of 
obesity have increased adipocyte size, numbers or both (Cleary et al., 1979). 
Adipogenesis probably continues throughout life at a low rate until energy-
storage demands promote further differentiation. A very interesting data came 
recently from Spalding and colleagues on this issue. Spalding and colleagues' 
results show that fat cells have a high turnover such that new cells are 
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continually being born to replace their dead predecessors. The average age of a 
fat cell seems to be about 10 years in both lean and obese individuals, and the 
number of fat cells as a proportion of all cells remains constant in each weight 
group. But the total number of new fat cells is higher in obese subjects, 
suggesting that they are replenishing an existing larger pool. This suggests that 
adipocyte hyperplasia might have more impact on obesity than recently 
appreciated (Spalding et al., 2008). 
 One other disease related to adipocyte differentiation is lipodystrophy. 
When adipocytes are absent, in these patients, lipids accumulate in muscle, liver 
and other peripheral locations. This causes insulin resistance and steatosis that 
leads to cirrhosis (Herranz et al., 2008; Reue and Peterfy, 2000; Thiebaut et al., 
2000). In addition, due to the lack of adipose, some of these patients have 
extremely low levels of leptin and other adipokines, which was lately considered 
to be the cause for insulin resistance and diabetes. Consistent with this, leptin 
treatment of patients with congenital lipodystrophies improved these metabolic 
abnormalities associated with their disease (Oral et al., 2002; Wolfsdorf et al., 
2002). Several genetic causes of lipodystrophy have been discovered in the past 
few years. Some of these mutations include adipogenesis related genes such as 
PPARƔ and AGPAT2 (Rosen and MacDougald, 2006). Similarly, overexpression 
of dominant negative C/EBP and mutation of lipin-1 causes lipodystrophy in 






Materials and Methods 
Animal Experiments:  
7 to 8 week old C57Bl/6 mice were purchased from the Jackson 
Laboratory, individually caged, and allowed to acclimate. All experiments were 
performed according to Rockefeller University CBC guidelines under protocol 
number 06055. 
Leptin treatment procedure is performed as previously described using 
Alzet subcutaneous pumps. Wild type animals are treated leptin at 2.5 µg/hour 
and ob/ob animals are treated 150ng/hour. Animals were PBS (6) or leptin (6) 
treated as described (Cohen et al., 2002).  Animals were sacrificed and fat 
tissues were isolated. Fat tissue from each animal were dissociated by 1.5mg/ml 
collogenase in Krebs-Ringer buffer as described.(Soukas et al., 2001a) RNA was 
isolated from stromavascular fraction and TAQMAN RT-PCR was performed.  
For leptin withdrawal experiment, PBS (PBS control group) or leptin at 2.5 
µg/hour (Leptin-FF and Leptin-NC groups) or was administered for 8 days by 
subcutaneous implanted osmotic pump (Alza, Palo Alto, CA). On day 8, leptin or 
PBS treatment was withdrawn by removing pumps under inhaled anesthesia. 
Body mass and food intake were monitored daily at 1200h. Animals were free-
fed (Leptin-FF and PBS groups) or maintained at the level of food intake prior to 
leptin withdrawal (Leptin-NC group). Mice were sacrificed at 1200 h on days 6 
and 8 of leptin treatment (PBS and Leptin groups) and 1, 2, 3, and 4 days after 
33 
 
pumps had been withdrawn (PBS, Leptin-FF and Leptin-NC groups). Serum and 
peri-uterine white adipose tissue were collected and kept at -80 °C for later 
analyses. Serum leptin (R&D Systems, Minneapolis, MN) and insulin (Crystal 
Chem, Chicago, IL) were measured by ELISA according to the manufacturers 
protocols.  
BAC modifications and in-vitro / in vivo imaging:  
Modification of BACs has been performed as described (Warming et al., 
2005) (Gong et al., 2003). Firefly luciferase is from Promega. Generation of 
transgenic mice following microinjection was based on standard techniques 
described by Hogan and colleagues (Hogan B. , 1994). In each case, leptin 
luciferase animals were killed and tissues; fat, spleen, kidney, brain, colon, liver, 
intestine, heart were isolated and lysed in passive lysis buffer (Promega). 
Luciferase activity was measured using Luciferase Assay Kit (Promega). Protein 
normalization was performed after protein measurements using the BCA (Pierce) 
kit according to the manufacturer’s instructions. 
In vivo imaging of transgenic animals was performed using the Xenogen 
IVIS Lumina imaging system.  Anesthetised animals were injected intraperitonally 
with the luciferase substrate, luciferin (200 μl of stock 15 mg/ml in PBS). After 15-
20 min, the animals were placed in a dark imaging chamber under isoflurane 
anesthesia. Photon emission resulting from the luciferin/luciferase reaction was 
detected with a sensitive CCD camera. This photon image was superimposed on 
a normal video image of the mouse with Living Image 3.0 software (Xenogen). 
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 White Adipose Tissue Histology and Glycogen Quantitation:  
Tissue fragments were embedded in paraffin wax (Paraplast Plus, Fisher 
Scientific, Morris Plains, NJ). Sections were PAS stained and hemaxoxylin 
counterstained according to standard protocol (Sigma). To demonstrate 
specificity of glycogen staining, several sections were pre-incubated for 5 
minutes at 37 °C in 5 mg/ml α-amylase (Sigma) after re-hydration prior to PAS 
staining. Glycogen was quantitated with the amyloglucosidase method.(Keppler, 
1974) For periodic acid-schiff (PAS) staining, to avoid loss of water soluble 
glycogen, small pieces of tissue (50 mg) were incubated overnight in alcoholic 
fixative (90% ethanol, 10% formaldehyde).  
Plasmids: 
For overxpression studies, KLF4 cDNA was cloned by RT-PCR and an HA 
epitope was added at the C terminus. It was subsequently inserted into 
pMSCVpuro (Clontech). Other pMSCV vectors are as used in Chen et al (Chen 
et al., 2005a). FLAG-KLF4 is courtesy of Douglas Boyd.  
For knockdown of KLF4, Krox20 or C/EBPβ expression in 3T3-L1 cells, 
the DNA-based, retroviral vector-mediated siRNA technology was used. The 
targeted sequence was determined by the Whitehead Institute siRNA designing 
tool and verified by BLAST searches to ensure specificity. Two complementary 
oligos for each targeted sequence were then designed according to the protocol 
of Clontech’s RNAi-Ready pSIREN-RetroQ system, annealed, and ligated into 
the BamHI/EcoRI-linearized pSIREN-RetroQ vector. The resulting plasmid, upon 
35 
 
packaged into retrovirus, allowed stable expression of siRNA hairpin for a 
specific gene.  All sequences for the siRNA constructs are as described in Chen 
et al (Chen et al., 2005a).   
Retroviral infections and 3T3-L1 differentiations: 
Recombinant pMSCV or pSIREN-RetroQ viral packaging was achieved by 
transfection of the plasmid into Phoenix ecotropic packaging cells (cultured in 
DMEM with 10% FBS in 5% CO2) using Fugene6 (Roche).  Viral supernatants 
were supplemented with 8 μg/ml polybrene and added to cells for infections for 
18–24 hr.  Cells were selected with 2μg/ml puromycin or 100 μg/ml hygromycin 
(Sigma), expanded, and seeded for differentiation experiments.   3T3-L1 cells 
(ATCC) were maintained in DMEM with 10% FBS (Invitrogen) in 5% CO2
Coimmunoprecipitation 
.  Stable 
cell lines from retroviral transduction were cultured to confluence and exposed to 
the differentiation cocktail (1 μg/ml insulin, 0.25 μg/ml dexamethasone, 0.5 mM 
IBMX).  After 48 hr, cells were maintained in medium containing 1 μg/ml insulin 
until day 8 for harvest.  Plates were oil-red O stained as described earlier 
(Soukas et al., 2001a). In experiments, where each component is added 
separately or in groups, the concentrations are as in the standard hormone 
cocktail. 
293T cells grown in DMEM supplemented with 10% FBS were transiently 
transfected using Fugene6 (Roche) according to the manufacturer’s 
recommendations.  Transfected cells were harvested in BA300 buffer (BA0 with 
300mM NaCl) after 36h, and lysates were used for coimmunoprecipitation as 
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described (Dou et al., 2005).  Briefly, lysate expressing indicated plasmids were 
immunoprecipitated by M2 agarose beads (Sigma) and washed extensively for 3 
times.  Beads were denatured with SDS-PAGE loading dye, and supernatants 
RT-PCR analysis 
were separated on 12% SDS-PAGE gels and western blotting was performed by 
anti-HA. (Sigma-H6908) 
Total RNA was isolated from cells by QIAGEN RNA prep kit following 
TRIZOL reagent (Invitrogen). Real Time PCR was performed by the Taqman 
system (Applied Biosystems) according to the manufacturer’s instructions. Oligos 
were designed by the PrimerExpress software. Amount of expression was 
normalized with cyclophilin for cell culture experiments and with ELK3 for 
preadipocyte fraction experiments. Sequences of the Taqman primers and 
probes are available in Supplementary methods. 
Transfection and reporter assays. 
C/EBPβ reporter was kindly provided by Daniel Lane.  Deletions were 
made by PCR and cloned into pGL3 plasmid.  (Primers are available upon 
request.)  The reporter plasmids along with effector plasmids were transfected 
using Fugene6 into 293T cells at 80-90% confluence.  The pRL-TK (Promega) 
that carries Rennila luciferase was also cotransfected as an internal control for 
transfection efficiency. Cells were harvested after 20-24h and luciferase activities 





KLF4 was cloned by PCR from pMSCVpuro-KLF4 and subsequently 
inserted into pGEX-T1 plasmid to express GST-KLF4 protein. GST-KLF4 protein 
is isolated as described (Morlon and Sassone-Corsi, 2003).  In vitro transcription 
and translation of the Krox20 protein was performed by using the TNT T7 quick-
coupled transcription-translation kit (Promega).   
GST pull-down assays were performed by incubating GST fusion proteins 
immobilized on GST beads with in vitro-translated 35
CHIP assays 
S-labeled Krox20 or 
Luciferase. After washing, bound proteins were isolated by eluting the proteins 
with 2× SDS buffer, separating them on SDS/PAGE, and developing by 
autoradiography. 
ChIP assay Kit (Upstate Biotechnology, Lake Placid, NY) was used 
according to the method recommended by the manufacturer, with minor 
modifications. In brief, a plate of cells was fixed in the presence 
of1%formaldehyde for 10 min at room temperature. The reaction was stopped by 
the addition of glycine at a final concentration 0.125 M. A soluble chromatin 
fraction containing fragmented DNA of 500–2,000 bp was obtained after cell lysis 
and sonication. The fraction was diluted ten times and precleared by using 
Protein A agarose slurry.  
Samples were incubated with Rabbit anti-KLF4 (santa cruz) or rabbit-IgG 
as a control, later mmunoprecipitated and DNA was used for PCR. 
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SDS-PAGE and Immunoblotting:  
Proteins were separated by SDS-PAGE using pre-cast 4-20% or 12% 
SDS gels (Bio-Rad) and transferred 
Gel shift assays 
to nitrocellulose membranes.  Western blot 
has been performed as described (Boyer-Guittaut et al., 2005).  Briefly, total 
protein lysate (20–50 μg) was loaded on SDS-PAGE for each sample. Rabbit 
anti-KLF4, rabbit anti-C/EBPβ, and mouse anti-TBP were from Santa Cruz (H-
180, C-19, and N-12, respectively). HRP-conjugated anti-rabbit and anti-mouse 
secondary antibodies were from Amersham(GE). 
EMSA was performed by incubating 5 ug of Nuclear extracts or 100ng of 
purified protein at room temperature for 20 min in a 30-µl binding reaction mixture 
containing 10 mM HEPES, pH 7.9, 80 mM KCl, 5% glycerol, 30 ng of poly(dI-dC), 
75 ng of denatured salmon sperm DNA, 10 mM dithiothreitol, and 30,000 cpm of 
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P-labeled double-stranded DNA probe. Following incubation, reaction mixtures 
were loaded on a 5-7% polyacrylamide gel, dried, and subjected to 
autoradiography.  
A 500-fold molar excess of unlabeled probe was added for competition as 
indicated in the appropriate figures. For competition experiments, proteins were 
preincubated for 20 minutes at room temperature with unlabeled probe at 
specified -fold excess. Labeled probe was then added and incubated for 20 min 
at room temperature.  
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Whole mount staining 
 Mice were sacrificed by cervical dislocation, after which the epididymal fat 
was removed using sterile techniques and minced into small pieces (~2-3 mm) 
using a scalpel. The tissue pieces were then washed and incubated with 
LipidTox, and/or Griffonia simplicifolia isolectin GS-IB4 conjugated with Alexa 
Fluor (Molecular Probes) before observation. Nuclei were counterstained with 
Hoecst 33342 (Molecular Probes). Griffonia simplicifolia IB4 isolectin is 
reportedly a useful histochemical probe that specifically labels endothelial cells in 
many species and tissues, including adipose tissue. 
 Confocal microscopy 
 A confocal laser scanning microscope (LSM510 Meta; Carl Zeiss) 
equipped with 10x dry, 40x dry, and 63x oil objectives was used to collect stacks 
of images at regular intervals along the optical axis. The tissue was excited using 
multiple color laser lines, and the emission was collected through appropriate 
narrow band-pass filters. Each image was produced from an average of 8 frames 
after which the acquired images were processed to produce a surface-rendered 
3-dimensional model. In preliminary experiments, adipose tissue was observed 
using 5-μm-thick stacks of images obtained at 0.5-μm intervals and 50-μm-thick 








CHAPTER 3:  
Transcriptional Networks in Early Regulation of Adipogenesis 
Introduction 
Two decades of research have revealed that adipogenesis is controlled by 
a complex network of transcription factors, including numerous transcriptional 
activators, coactivators and repressors (Farmer, 2006a).  When confluent 3T3-L1 
and 3T3-F442A cell lines are exposed to a cocktail of hormonal stimulants, these 
cell lines accumulate lipid and develop the characteristic morphology of mature 
adipocytes (Green and Meuth, 1975).  The earliest inductive event in this process 
is transcriptional activation of two of the C/EBP family of transcription factors, 
C/EBPβ and C/EBPδ, which then stimulate expression of PPARƔ, the late major 
transcription factor (Cao et al., 1991; Lane et al., 1999; Wu et al., 1995; Yeh et 
al., 1995).  PPARƔ is necessary and sufficient for adipocyte differentiation 
(Tontonoz et al., 1994d). Less is known about what controls C/EBP gene 
expression.  The identification of the factors that regulate these important early 
genes in preadipocytes would provide additional insight into the mechanisms 
regulating the initiation of fat cell differentiation. 
In order to study the earlier transcription factors, it was considered that 
these factors might be included in a panel of transcription factors that are 
expressed at a much higher level in white adipose tissue in vivo than in 3T3-L1 
cells in vitro. This approach yielded two early transcription factors, Krox20 and 
KLF4.  However, a role of KLF4 in adipogenesis has not been previously 
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demonstrated. KLF4, also known as GKLF/ZIF, is highly expressed in 
differentiated, post-mitotic cells of the skin and the gastrointestinal tract and it 
has been suggested to have variety of roles as differentiation-proliferation switch 
and control of the cell cycle (Garrett-Sinha et al., 1996; Shields et al., 1996; 
Takahashi and Yamanaka, 2006; Yoon et al., 2003). KLF4 knockout mice die 
around 12 hours after birth due to defects in skin development with a failure of 
normal basement membrane formation (Segre et al., 1999). In these mice, the 
skin’s fat layer is disrupted, causing the loss of skin barrier function and rapid 
loss of body fluids (Segre et al., 1999).  
I thus considered the possibility that KLF4 might play a role in regulating 
the development of adipose tissue and tested this possibility by studying the 
functional role of KLF4 during the differentiation of 3T3L1 adipocytes. 
Results 
Several transcription factors are expressed highly in in vivo adipose 
tissue compared to in vitro differentiated adipocytes 
A previous microarray analysis has been done by Soukas et al in order to 
characterize factors that might regulate leptin gene expression by comparing in 
vivo versus in vitro adipocytes (Soukas et al., 2001a). However, since adipose 
tissue also contains other cell types (stromavascular fraction), we considered the 
possibility that early factors that are expressed in the stromavascular fraction 
might be included in this panel of transcription factors that are expressed at a 
much higher level in white adipose tissue in vivo than in 3T3-L1 cells in vitro 
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(Soukas et al., 2001a). Among these transcription factors, Krox20 has been 
characterized as one of the earlier factors, validating this microarray approach 
(Chen et al., 2005b) (Figure 9). 
 
Figure 9 In vivo enriched transcription factors.  
This figure shows the in vivo adipose-tissue enriched transcription factors. Left side of the graph 
shows the expression of each transcription factor during 3T3-L1 differentiation time course. WAT: 
White adipose tissue 
One of the other transcription factors that is induced in vivo is KLF4, a 
member of a large family of zinc-finger proteins that is known to play important 
roles in differentiation and proliferation (Ghaleb et al., 2005).  Several other KLFs 
have previously been implicated in the regulation of adipogenesis.  KLF6 and 
KLF15 have both been shown to promote adipogenesis and KLF15 also 
upregulates GLUT4 expression (Boquest et al., 2005; Halaas et al., 2005).  In 
addition, another KLF factor, KLF5, is necessary for adipocyte differentiation and 




Figure 10 Expression of KLF4 during 3T3-L1 differentiation 
A) The expression of KLF4 during differentiation of 3T3-L1 cells was analyzed using Taqman RT-
PCR and (B) Western blots. Cells were harvested at the indicated times. Cyclophilin was used as 
an internal control for Taqman analysis.  
C) Expression of early genes in stromavascular fraction and adipocyte fraction. Taqman RT-PCR 
was performed in stromavascular and adipocyte fractions of the adipose tissue disintegrated by 
collagenase. Leptin levels (enriched in the adipose fraction) were checked as a control of the 
preparation.  Error bars are SEM.  
factors are thought to function through different coactivators or repressors 
(Farmer, 2006a). 
KLF4 is an early-expressed and necessary factor during 3T3-L1 
differentiation  
To assess if KLF4 is an early factor, KLF4 gene expression was assayed 
at numerous times early during 3T3-L1 differentiation that was induced using the 
standard IBMX, dexamethosone, and insulin cocktail.  Quantitative RT-PCR 
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revealed that KLF4 mRNA appeared 30 min post-induction and peaked at 2 hr 
post-induction.  Protein levels for KLF4 were consistent with the mRNA levels 
(Figure 10).  This result shows that KLF4 is expressed very early in the course of 
3T3-L1 differentiation with a similar pattern to other previously described early 
transcription factors (Figure 10) including Krox 20, C/EBPβ and C/EBPδ. These 
same factors were also enriched in the stromal/pre-adipocyte fraction of the 
adipose tissue compared to the adipocyte fraction (Figure 10C). 
 
Figure 11 KLF4 is necessary for adipogenesis 
KLF4 knock-down impairs adipogenesis. 3T3-L1 cells were infected with pSIREN-RetroQ-derived 
retroviruses carrying either siRNA oligos for KLF4 or control oligo, selected for puromycin 
resistance, expanded as mixed population and induced to differentiate using MDI cocktail. The 
upper panel (A) shows the efficiency of the 2 knock-down plasmids against KLF4 by Taqman 
assays. (B) Right panel shows expression levels of fat markers aP2, PPARƔ2, adipsin and an 
early gene, C/EBPβ  in control and KLF4 knock-down 3T3-L1 cell lines at different time points 
during differentiation. 
C) ORO staining of KLF4 knock-down and control hairpin cell lines at day 8. 
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The role of KLF4 in adipogenesis was tested using retroviruses carrying 
siRNA for KLF4, to knock down its expression.  Two independent hairpin siRNA 
sequences for KLF4 (cloned into pSIREN-RetroQ-puro retroviral plasmid) were 
effective for knocking down KLF4 expression (Figure 11). 3T3-L1 cells were 
infected with the two KLF4 siRNA-containing retroviruses along with a control 
hairpin.  After selection with puromycin, we established stable cell lines with 
constitutive siRNA expression.  Note, these cell lines were a mixture of all cells 
expressing the selectable marker and were not clonal.  These stable cell lines 
were cultured to confluence and differentiated using the standard induction 
cocktail for 8 days.  Oil red O staining revealed that both KLF4 knock down cell 
lines accumulated significantly less lipid than the control cell line. (Figure 11C)  
RNA levels of adipogenic regulators such as adipsin, ap2 and PPARƔ2 were also 
reduced consistent with the oil red-O staining. In addition, early C/EBPβ 
expression was also reduced in KLF4 knock down cell lines compared to control 
cells (Figure 11B).  These results suggest that KLF4 is necessary for normal 
differentiation of 3T3-L1 cells and acts upstream of C/EBPβ and PPARƔ. Of note 
however, the reduction of PPARƔ gene expression was not proportional to the 
decrease in adipogenesis suggesting that KLF4 might partially promote the 
differentiation of adipocytes independent of PPARƔ. 
KLF4 transactivates C/EBPβ at a conserved -1.45kb to -1.1 kb region 
of the C/EBPβ promoter 
The data shown above suggested that KLF4 might regulate C/EBPβ 
transcription.  To test this hypothesis, a virus expressing a KLF4-HA-protein and 
46 
 
a control plasmid were cotransfected into 293T cells with a promoter-luciferase 
reporter plasmid (B3K), which contains 3kb of the C/EBPβ promoter(This 
construct was generously provided by Daniel Lane).  These showed that KLF4 
transactivated the C/EBPβ promoter (B3K) by ~10 fold, in a dose dependent 
manner (Figure 12A). 
 
Figure 12 KLF4 transactivates the C/EBPβ promoter 
A) Transactivation of C/EBPβ plasmid by KLF4 
B) A deletion series derived from of a luciferase reporter construct (B3K), carrying 3kb promoter 
region of C/EBPβ (generously provided by Daniel Lane) was cotransfected with 250ng of 
pMSCV-KLF4 and pRL-TK(Renilla). Results were expressed as firefly luciferase activity 
normalized for renilla luciferase activity. 
C) CHIP analysis of KLF4 binding to the target region on C/EBPβ promoter. 3T3-L1 cells were 
fixed 2.5h post-differentiation and chromatin samples were subjected to CHIP assays by using a 
KLF4 antibody or normal rabbit IgG as a control. An upstream region (-2.5kb) in C/EBPβ 
promoter was also checked as negative control. 
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To further narrow down the region(s) responsible for the transactivation 
To assess whether KLF4 directly activated the C/EBPβ gene, I next 
assayed the binding of KLF4 to the endogenous C/EBPβ promoter in 3T3-L1 
cells using chromatin
of 
KLF4, a series of 5' deletions of the C/EBPβ promoter was generated and 
analyzed for the induction in response to KLF4. Transactivation by KLF4 dropped 
by more than 5 fold, when a region from -1.45kb to -1.1kb was deleted (Figure 
12B). Deletion of sequences from -3kb to -1.5kb region resulted in a further 2-fold 
decrease in the activation. 
 immunoprecipitation assays 3T3-L1 cells were differentiated 
for 2.5 hours at which time DNA-protein complexes were cross-linked and CHIP 
assay was performed by using an anti-KLF4 antibody, or rabbit IgG as a control. 
Chromatin precipitation using the anti-KLF4 antibody caused a significant 
enrichment of the C/EBPβ promoter sequence indicating that the KLF4 
transcription factor is directly bound to the C/EBPβ promoter (Figure 12C). 
Further characterization of the region between -1.45 to – 1.1 kb of the C/EBPβ 
promoter was performed using gel shift assays with fragments of the promoter 
and bacterially expressed Klf4. Seven 55bp oligos spanning the 1.45kb-1.1kb 
region were incubated with recombinant GST-KLF4 protein. GST-KLF4 shifted 3 
of these oligos and this was correlated with the results of a cotransfection of Klf4 
with a series of C/EBPΒ promoter deletions between -1.45 to – 1.1 kb. (Figure 
13) Same binding could not be seen by Krox20. Taken together, these findings 
suggest that KLF4 transactivates C/EBPβ gene by binding directly to several 
sites on 1.45kb-1.1kb region of the promoter. However the sequences of these 
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oligonucleotides were different and DNAse footprinting failed to reveal a clear 
consensus sequence (data not shown). This suggests that the Klf4 binding site 





Figure 13: KLF4 binds C/EBPβ promoter 
Gel shift assay with 293T nuclear extracts overexpressing KLF4 (C) or purified GST-KLF4 (A) 
Seven 55bp oligos spanning the 1.45kb-1.1kb region were checked for their ability to bind to 
nuclear extracts or recombinant GST-KLF4 protein. B) A deletion series between 1.45-1.1 kb 
fragment derived from of a luciferase reporter construct (B3K) was cotransfected with 250ng of 
pMSCV-KLF4 and pRL-TK (Renilla). Results were expressed as firefly luciferase activity 
normalized for renilla luciferase activity. 
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KLF4 and Krox20 interact and transactivate the same site of the 
C/EBPβ promoter 
Krox20 transactivates the C/EBPβ promoter via sequences between 
1.45kb-1.1kb which is identical to that reported above for Klf4 (Figure 14B). The 
fact that KLF4 and Krox20 also have similar expression kinetics led us to 
examine whether the ability of these transcription factors to activate C/EBPβ 
promoter is synergistic.  Plasmids directing the expression of Krox20 and KLF4 
were co-transfected into 293T cells using the same C/EBPβ promoter-luciferase 
reporter.  Transfection of KLF4 or Krox20 alone led to a 6-fold and 4-fold 
induction respectively, while simultaneous transfection of both plasmids 
increased the luciferase activity 10-fold (Figure 14C). 
Since Krox20 (Chen et al., 2005a) and KLF4 bind to the same region and 
can both activate transcription of C/EBPβ, I considered the possibility that these 
proteins might bind to one another.  Flag-tagged KLF4 and HA-tagged Krox20 
were ectopically expressed in 293T cells for 2 days and the lysate was 
immunoprecipitated using anti-FLAG M2 agarose beads (Sigma), washed 
extensively with BA300 (300mM NaCI) and immunoblotted using an ant-HA 
antibody. In this assay, immunoprecipitation of KLF4 using an antibody to the 
Flag tag pulled down Krox20 (Figure 15). In addition studies using standard 
mammalian 2-hybrid assay provided functional evidence that Krox20 and Klf4 
can bind to one another and activate gene expression (data not shown).  A 
cross-species comparison of the C/EBPβ promoter further indicated that the 
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1.45kb-1.1kb region is the only region that is significantly conserved among 
mammals (Figure 14C).  
 
 
Figure 14: Effect Krox20 and KLF4 on C/EBPβ promoter 
A) KLF4 and Krox20 expression plasmids were cotransfected with the C/EBPβ luciferase reporter 
construct. An additive effect for transactivating C/EBPβ promoter was shown. 
B) A deletion series derived from of a luciferase reporter construct (B3K), carrying 3kb promoter 
region of C/EBPβ (generously provided by Daniel Lane) was cotransfected with 250ng of 
pMSCV-Krox20 and pRL-TK (Renilla). Results were expressed as firefly luciferase activity 
normalized for renilla luciferase activity. 
 






Figure 15: Interaction of KLF4 and Krox20 
A) Coimmunoprecipitation of KLF4 with Krox20. FLAG-KLF4 and Krox20-HA were cotransfected 
into 293T cells. After 2 days, cells were lysed and co-immunoprecipitated using an anti-FLAG 
antibody and immunoblotted against HA. The data shows the specific binding of KLF4 to Krox20. 
B) GST pull-down assays. Krox20 and luciferase plasmids were in vitro translated in presence of 
S35, mixed with purified GST-KLF4 and pulled-down by GST beads. Krox20 but not luciferase 




Krox20 and C/EBPβ overexpression partially overcomes the 
knockdown of KLF4 
The data suggested that Klf4 acted upstream of C/EBPβ. If true, 
expectation would be that overexpression of C/EBPβ or Krox20 should bypass 
the effect of KLF4 knockdown. To test this, 3T3-L1 cells were infected with 
retroviruses carrying KLF4 siRNAs and either Krox20-HA or C/EBPβ. These data 
confirmed that the negative effect of a KLF4 knockdown on adipogenesis can be 
ameliorated by the overexpression of either Krox20 or C/EBPβ as assessed 
using Oil red O staining and measuring the level of expression of aP2, adipsin 
and PPARƔ2 (Figure 16).  
KLF4 expression is dependent on IBMX but not on Dexamethasone 
or Insulin 
These data show that KLF4 and Krox 20 cooperate to activate C/EBPβ 
transcription and establish them as among the earliest if not the earliest factors 
induced during adipogenesis.  If this is true, both factors might be expected to 
respond directly to one of the components of the adipogenic cocktail and not the 
others.  To test this, confluent 3T3 cells were exposed individually to each of the 
three components of the induction cocktail: insulin, dexamethasone, and the 
phosphodiesterase inhibitor IBMX.  Insulin and dexamethasone concentrations 
did not change KLF4 levels at 2 hr post-induction, the time at which KLF4 is 
maximally induced in response to the three-component cocktail. On the other 
hand, IBMX increased KLF4 levels 4 to 5 fold (Figure 17) and increasing 
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concentrations of IBMX proportionally increased C/EBPβ and KLF4 gene 




Figure 16 Krox20 and C/EBPβ overexpression partially overcomes the knockdown of KLF4 
3T3-L1 cells were coinfected with pMSCVhyg-derived retroviruses carrying either Krox20-HA/ 
C/EBPβ or control insert and pSIREN-RetroQ-derived retroviruses carrying either siRNA oligos 
for KLF4 or control oligo, selected for hygromycin and puromycin resistance, and induced to 
differentiate till day 7. 
A) Overexpression of Krox20 overcomes the knockdown of KLF4. Upper panel shows the oil red 
O staining and lower panel shows the TAQMAN analysis of 3 late genes, aP2, adipsin and 
PPARƔ2.  
B) Overexpression of C/EBPβ overcomes the knockdown of KLF4. Upper panel shows the oil red 





To further assess the effect of IBMX on KLF4 in 3T3-L1 cells, 293T cells 
were transfected with a luciferase reporter driven by 2 kb KLF4 promoter.  When 
the transfected cells were exposed to IBMX, 3 to 4 fold increase in luciferase 
activity was observed (Figure 17C). 
KLF4 and Krox20 are regulated through a negative feedback loop 
Overall these data suggest that KLF4, Krox 20 and C/EBPβ compose a 
network of transcription factors that play a key role in orchestrating the early 
events of adipogenesis.  The interaction among these factors was checked by 
analyzing their expression in cells in which only one of these transcription factors 
was knocked down by stable expression of their corresponding siRNA.   The 
C/EBPβ knockdown cell lines showed a robust 2 fold increase in Krox20 and 
KLF4 expression levels at 2 hours post-induction, suggesting that C/EBPβ 
expression normally inhibits its upstream activators via a negative feedback 
mechanism. These data add further evidence that it is a downstream target of 
KLF4 and Krox20 (Figure 18A).  
Consistent with the hypothesis, a 3T3L1 cell line that over expressed 
C/EBPβ showed a robust early decrease of KLF4, and to a lesser extent in 
Krox20 expression levels (Figure 18B).  A negative effect of C/EBPβ on KLF4 
expression was also seen using the KFL4-luciferase reporter.  Co-expression of 
the KLF4-luciferase reporter with C/EBPβ in 293T cells reduced KLF4 expression 
as much as 30% and was dose-dependent.  This inhibition was even more 




Figure 17 KLF4 expression is dependent on IBMX 
A) Individual components of the induction cocktail (IBMX,dexamethasone and insulin) were 
added onto confluent 3T3-L1 cells alone or in combination. Cells were harvested 2h post-
treatment for Taqman analysis of KLF4. Panel shows the effect of each component on gene 
expression. B) The left panel shows dose-dependent induction of KLF4 and C/EBPβ. Confluent 
3T3-L1 cells were treated by increasing amounts of IBMX (0 to 0.5 mM). Cells were harvested 
2h-post induction for Taqman Analysis. 
C) IBMX can transactivate C/EBPβ promoter in 293T cells in vitro. 293T cells were transfected 
with KLF4 luciferase reporter plasmid carrying 2kb upstream of KLF4 promoter. 16 hours later, 
the cells were either treated with DMSO or 0.5mM IBMX for 8 hours.  After treatment, cells were 






Figure 18: KLF4 and Krox20 are regulated by C/EBPβ through a negative feedback loop 
3T3-L1 cells were infected with retroviruses expressing C/EBPβ knockdown or overexpression 
constructs. Cells were selected, differentiated and the effect of C/EBPβ expression on KLF4 was 
observed. 
A) KLF4 and Krox20 levels are upregulated in C/EBPβ knockdown 3T3-L1 cells. 
B) KLF4 and Krox20 levels are downregulated in C/EBPβ overexpressing 3T3-L1 cells 
   
  Overall, these results suggest a potential negative feedback mechanism 
whereby C/EBPβ actively down-regulates its upstream regulators and add further 
evidence to the possibility that KLF4 and Krox20 act upstream of C/EBPβ. 
Overall, these data indicate that the level of expression of Klf4 is tightly 
controlled, a finding that is consistent with the observation the overexpression of 
Klf4 leads to cell cycle arrest in preadipocytes (and other cell types) further 
suggesting that Klf4 must be expressed at tightly regulated levels in a narrow 
window during adipogenesis.  
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p300 co-activates KLF4/Krox20 dependent C/EBPβ expression 
In order to assess the effect of possible coactivators of this early 
regulatory network, several co-activators including GRIP-1, SRC-1,TRAP220 and 
p300 were cotransfected along with KLF4, Krox20 and both. This experiment 
showed that p300 has the most co-activation potential in this context (Figure 20). 
 
Figure 19: KLF4 transcription is inhibited by C/EBPβ.  
293T cells were cotransfected with increasing amounts of C/EBPβ plasmid along with a luciferase 
reporter plasmid carrying 2kb promoter of KLF4. After 16 hours the cells were treated with DMSO 
or 0.5mM IBMX. Cells were harvested after 8 hours for luciferase assays. 
Leptin treatment down-regulates early genes including KLF4 in the 
preadipocyte fraction 
Leptin treatment of ob/ob mice reduces food intake and body mass, and 
has been suggested to decrease adipogenesis particularly in ob mice compared 
to PBS treated controls. Fat tissue from 12-day leptin or PBS treated ob animals 
was isolated and RNA was prepared from the preadpocyte fraction.  The 
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expression levels of KLF4, Krox20, C/EBPβ and C/EBPβ were measured using 
specific TAQMAN assays.  All of these early genes were downregulated by 
approximately 2-fold in the preadipocyte fraction in 12 day leptin treated animals 
compared to 12d PBS treated animals (Figure 21). 
 
Figure 20: p300 is the predominant coactivator of KLF4 in vitro. 
The KLF4 and Krox20 plasmids were transfected into 293T cells along with the luciferase reporter 
carrying 3kb C/EBPβ promoter and a series of coactivators. Results were normalized by Renilla 
Luciferase. 
Discussion 
Adipogenesis is controlled by a cascade of transcription factors that act to 
induce the expression of gene products necessary for the acquisition of the 
characteristic morphology and specialized functions of adipocytes (Farmer, 
2006a).  Previously C/EBPβ has been shown to be among the first transcription 
factors activated during adipogenesis and it is considered to be one of the 
initiators of a transcriptional cascade, which in turn activates C/EBPβ and 
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PPARƔ2 (Rosen et al., 2002).  These latter genes then activate the genes that 
mark the fully differentiated adipocyte phenotype.  However, the upstream factors 
regulating C/EBPβ expression have not been characterized.   
 
Figure 21: Leptin treatment reduces expression of early genes in stromavascular fraction.  
6 ob/ob animals were treated with leptin or PBS. Animals were sacrificed after 12 days leptin/PBS 
treatment and stromavascular fraction was collected for Taqman assay. 
 
KLF4 gene expression is induced early during adipogenesis in response 
to IBMX, one of the components of the standard induction cocktail. KLF4 
knockdown cell lines showed a marked decrease in adipogenesis as assessed 
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using Oil Red O and reduced expression of differentiated fat markers such as 
aP2, adipsin and PPARƔ2. However, the decrease in PPARƔ2 expression 
seems to be less prominent than for the other two markers suggesting that Klf4 
might have PPARƔ2-independent effects. KLF4 knock-down cells also showed 
reduced expression of C/EBPβ, adding functional evidence to support the 
conclusion that KLF4 is upstream factor of C/EBPβ in the transcriptional network 
controlling adipogenesis.  Consistent with this, KLF4 is able to transactivate a 
luciferase reporter driven by 3kb C/EBPβ promoter in a dose dependent manner, 
and a deletion series further localized the critical region to between −1438 and 
−1134 base pairs. CHIP assays and gel shift assays confirmed the binding of 
KLF4 to C/EBPβ promoter at this conserved critical region.  KLF4 seems to bind 
several sites along this region as assessed by footprinting studies.  The 
extensive homology of this region of the C/EBPβ promoter suggests that these 
promoter sequences are functionally important. Note that, Krox20 could not be 
shown to bind C/EBPβ promoter in both Chromatin IP assays and gel shift 
assays. This suggests that Krox20 may be acting on C/EBPβ promoter through 
KLF4. It is also possible that Krox20 binding to C/EBPβ promoter requires an 
interaction with other unidentified partners.  
Krox20 has previously been shown to activate C/EBPβ promoter in the 
same promoter region (Chen et al., 2005a). Klf4 and Krox20 trans-activation is 
additive with KLF4, suggesting that both factors cooperate to activate C/EBPβ 
expression in adipogenesis. In addition, overexpression of either Krox20 or 
C/EBPβ seems to bypass KLF4 knockdown phenotype, further supporting the 
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role of Krox20 and KLF4 to activate C/EBPβ. It was also shown that, in 
cooperation with p300 these two factors potently transactivate C/EBPβ promoter. 
Consistent with this, ribozyme-mediated targeting of p300/CBP suppresses 
differentiation of 3T3-L1 preadipocytes into adipocytes, indicating that p300 is 
also necessary for adipogenesis (Takahashi et al., 2002).  p300 has been 
previously shown to interact directly with KLF4 by using pull-down assays 
(Feinberg et al., 2005).  These data suggest that p300 might play a role in early 
phases of adipogenesis via interactions with Krox20 and KLF4 potentially with 
other proteins to form a protein complex that induces C/EBPβ and coordinates 
some (though not all, see below) of the key early events during adipogenesis. 
 
Figure 22: Early transcriptional network in adipogenesis 
KLF4, Krox20 and possibly p300 are a part of early transcriptional network acting on the early 
master regulator of adipogenesis, C/EBPβ. C/EBPβ, then, activates PPARƔ, leading to the 
transcription of adipogenic genes. 
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A knockdown of C/EBPβ increases the expression of KLF4 and the 
overexpression of C/EBPβ reduces KLF4 expression.  These data indicate that 
C/EBPβ acts downstream of KLF4 and reduces its expression by feedback 
inhibition.  Ectopic expression of KLF4 results in cell-cycle arrest in several cell 
lines including NIH3T3 cells and its transcriptional targets are involved in 
differentiation and cell-cycle inhibition (Chen et al., 2001; Chen et al., 2003; 
Shields et al., 1996).  Consistent with this, over-expression of KLF4 in 3T3L1 
cells leads to slow proliferation even before differentiation and these cells 
differentiate extremely poorly (data not shown). These results also suggest that 
the levels of KLF4 must be tightly controlled either quantitatively and/or 
temporally.  
 KLF4 is specifically activated by IBMX, an inducer of cAMP, but not by 
dexamethosone or insulin, the other two components of the adipgenic cocktail. 
IBMX by itself can partially induce adipocyte differentiation in 3T3L1 cells in vitro 
but IBMX treatment does not fully recapitulate the effects of the entire cocktail 
(Yeh et al., 1995).  This suggests that other factors activated by dexamethosone 
and insulin, in combination with KLF4, are necessary for the activation of the fully 
differentiated adipocyte phenotype.   
It is not known whether the failure of IBMX to fully activate adipogenesis is 
the result of a failure to fully induce the quantitative expression of downstream 
mediators such as C/EBPs or if additional, as yet unidentified factors are 
required.  The identification of these dexamethosone and insulin induced target 
genes would resolve this issue and advance our understanding of the earliest 
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events of adipogenesis.  It is not known however whether KLF induction by 
cAMP is a direct effect via PKA phosphorylation of CREB family transcription 
factors or if another mechanism contributes (Reusch et al., 2000a; Zhang et al., 
2004a).  The fact that CREB phosphorylation is required for early events in 
adipogenesis is consistent with this possibility (Reusch et al., 2000a). However, 
cotransfection of CREB with a KLF4-promoter-luciferase reporter construct in the 
presence of forskolin, did not show any increase in KLF4 expression (data not 
shown) suggesting that the effect of CREB on Klf4 expression is likely to be 
indirect. 
The role of KLF4 in vivo could be further tested in fat specific knockouts of 
KLF4 however the interpretation of such data could be complicated by the fact 
that the expression of KLF4 might not be required at later times in adipogenesis 
such as when the aP2 promoter is turned such as in aP2-cre or leptin-cre mice 
(unpublished data) (Jones et al., 2005a).  In other words, an aP2 directed 
knockout of KLF4 would not be informative, if KLF4 is not required for the 
maintenance of adipose tissue. The low levels of KLF4 in fully differentiated 
adipocytes are consistent with this possibility. Thus promoters that direct cre 
expression early in adipogenesis i.e. in preadipocytes is likely to be required to 
assess the inductive role of KLF4 in tissue specific knockouts.  Because such 
promoters are not known or available, the delineation of a role for KLF4 in vivo 
might require an ES cell complementation strategy analogous to that recently 
developed to study pancreatic development (Stanger et al., 2007).   
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 In summary, KLF4, here, is identified as an essential player in adipocyte 
differentiation (Figure 22). These findings put KLF4 among a group of key 
proadipogenic early transcription factors, including Krox20 and CREB (Reusch et 
al., 2000a; Zhang et al., 2004a). It seems that there is an earlier transcriptional 









CHAPTER 4:  
Characterization of Adipogenesis in vivo 
Introduction: 
Obesity can be a result of both hypertrophy, an increase in adipocyte size, 
and hyperplasia, an increase in cell number. In the previous section, an early 
adipogenic transcriptional network including Krox20, Klf4 and C/EBPβ was 
identified. However, those experiments were limited to the in vitro adipogenic 
processes (Fischbach et al., 2004) (Mandrup et al., 1997a). Unfortunately, the 
information regarding in vivo adipogenesis is very limited. On the way to study 
adipogenesis in vivo, a major issue is identifying the progenitor cells that make 
up the fat cells in adipose tissue. 
 
Figure 23 Scheme for identification of adipocyte progenitor cells 
SVF fraction is sorted based on several surface markers and injected in a conducive 
hyperadipogenic environment for growth. Cells can be tracked using an in vivo imaging assay 
without killing the animal. 
An experimental scheme for identifying the adipocyte progenitor fraction is 
as follows. Firstly, stromavascular fraction can be sorted using various cell 
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markers by fluorescence-activated cell sorting (FACS). Next, these cells can be 
transplanted into an in vivo model, preferably with a conducive adipogenic 
environment. Lastly, there is a need to monitor the growth of adipocytes from 
these cells (Figure 23). This scheme is analogous to previous assays employing 
precursor cell transplantation in vivo for the study of hematopoietic, mammary 
epithelial, and spermatogonial stem cells (Brinster and Zimmermann, 1994; 
Deome et al., 1959; Ford et al., 1956).  
Results 
A Lipodystrohic Model contains hyper-adipogenic/proliferative fat 
pads 
Lipodystrophy is a medical condition characterized by complete loss of fat 
depots and usually associated with hepatomegaly, hyperglycemia, insulin 
resistance, hyperlipidemia and hypermetabolism (Chinen, 2001; Hegele, 2000). 
One model of genetic lipodystrophy in rodents is A-ZIP lipodystrophic mouse 
model.  A-Zip lipodystrophic mice have a severe, generalized lack of WAT 
(Moitra et al., 1998), and retain very small WAT depots at the sites where mature 
WAT depots typically develop in wild type animals (Figure 24). These mice 
express a dominant-negative transcription factor (A-Zip) that inhibits C/EBP 
transcription factors under the control of the aP2 (FABP4) promoter (Moitra et al., 
1998). The transgene encodes a peptide, carrying an acidic portion, which binds 
to the B-ZIP leucine zipper transcription factors stronger than their corresponding 
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DNA binding site. Thus, this dominant negative peptide blocks the DNA binding 
of B-ZIP transcription factors such as C/EBPs.  
 
Figure 24 A-ZIP lipodystrophic animals 
A) Depiction of the dominant negative transgene of A-ZIP animals. Dominant negative peptide 
carries an acidic extension which binds to C/EBP factors with high affinity, preventing their 
binding to DNA. B) Overall morphology of lipodystrophic animals. The animal on the right side is 
lipodystrophic. Note the lack of any visible fat. C) Ventral view of the lower abdomen of female 
littermate wild-type (WT) and A-Zip mice at 12 weeks of age. The bladder (bl), uterus and 
fallopian tubes (ut), and parametrial WAT (adi) are indicated 
Since aP2 is expressed relatively late in adipogenesis it was reasoned 
that there might be an expansion of precursor cells upstream of this block in 
differentiation caused by the expression of the transgene.  It was also possible 
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that by blocking C/EBP and downstream factors, the negative feedback loop that 
inhibits KLF4 and Krox20 will not work, resulting in induction of these genes. 
 
Figure 25: Early genes are upregulated in A-ZIP remnant adipose organ 
A) Taqman RT-PCR was performed for the markers of early adipogenesis, Krox20, Klf4, and 
Cebpδ, as well as PPARƔ. RNA was isolated from adult A-Zip and WT parametrial adipose 
tissue. Results are shown as mean ± SEM, n = 3 (*, p < 0.05; **
As explained above, it was hypothesized that inhibition of the formation of 
mature adipocytes in the WAT depots of the A-Zip animals would lead to an 
increase of proliferation and differentiation of precursor cells upstream of the 
block in differentiation. If true, cells in the stromal fraction of these depots should 
, p < 0.001). B) Immunostaining of 
parametrial WAT from A-Zip and WT mice for the early markers of adipogenesis Krox20, Klf4, 
and phospho-CREB, as well as the proliferation marker BrdU, is shown. For BrdU incorporation 
analysis, mice were treated with BrdU for 7 days prior to immunostaining. 
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continue to express genes induced early during adipogenesis (upstream of the 
block induced by the transgene) and continually proliferate in a manner similar to 
the clonal expansion phase of adipogenesis in preadipocyte cells lines induced to 
differentiate in vitro. To test this, expression of genes typically induced early 
during adipogenesis were analyzed in the A-Zip WAT depots. It was found that 
RNAs for early markers of adipogenesis, Klf4, Krox20 and C/EBPδ, were 
increased in A-Zip WAT depots relative to wild type WAT by 191%, 498% and 
291%, respectively, while the expression of PPARγ, a marker of mature 
adipocytes, was decreased to 56% of the levels in wild type tissue (Figure 25A). 
Consistent with this, immunohistochemistry for Krox20 and Klf4 indicated very 
low expression of these factors at the protein level in wild type WAT with a 
significant increase in the numbers of Klf4 and Krox20 positive cells in A-Zip 
WAT (Figure 25B). In lipodystrophic WAT, there was also a similar increase in 
the level of CREB phosphorylation, one of the earliest events observed during 
adipogenesis in vitro (Zhang et al., 2004a) (Figure 25B).  
Above data suggests that A-ZIP adipose is hyperadipogenic. Since 
preadipocytes proliferate through clonal expansion in vitro, proliferation was 
tested in lipodystrophic WAT. Briefly, A-Zip mice were treated with BrdU for 
seven days and fat tissue sections were analyzed by immunohistochemistry. 
Analysis of BrdU incorporation showed that A-Zip adipose tissue contains large 
numbers of proliferating cells compared to wild type adipose in which there are 
barely detectable levels of BrdU incorporation, as expected due to its quiescent 
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state (Figure 25B). The percent of BrdU positive cells was significantly higher in 
lipodystrophic fat pads compared to wild type fat pads (Data not shown). 
These results, all together, 
suggest that A/ZIP mice can provide a 
conducive environment for the injection of 
candidate progenitor cell fractions, due to 
its hyperadipogenic/hyperproliferative 
environment. 
A luciferase transgenic model 
to study adipogenesis in vivo 
In order to follow the fate of 
adipose tissue under different conditions, 
a transgenic animal, in which luciferase is 
expressed under the control of leptin 
gene regulatory sequences, was 
generated. Leptin is highly enriched in 
adipose tissue and luciferase was chosen 
as the reporter since it can be quantified 
in vitro biochemically and in vivo by 
imaging anesthetized animals using a CCD camera. In vivo imaging allows one 
to monitor luciferase levels in the same animal over time, without having to 
sacrifice animals. 
Figure 26: Leptin-luciferase BAC 
transgenic animals 
Luciferase activity in tissues (A) and 
fractionated WAT isolated from leptin-
luciferase mice.(C) Luciferase can also be 
detected in the animals, using a CCD 
camera.(B) The indicated tissues were 
isolated, and luciferase activity was 
determined. Data shown are normalized to 
total protein in each lysate. Results are 





Leptin-luciferase transgenic animals were generated using BAC number 
RP24-69D4 from UCSC database. This BAC contains 22 kb of 5' sequence and 
160 kb of 3' sequence relative to the 
leptin transcription start site. The firefly 
luciferase-polyA (Promega) was inserted 
into the ATG site of the leptin BAC via 
homologous recombination and 
transgenic mice were generated by 
pronuclear injection of the modified BAC. 
All subsequent studies use the D7-1 line, 
which has nine copies of the modified 
BAC
Tissue specific expression of 
luciferase in leptin-luciferase transgenic 
animals was confirmed using 
biochemical assays from lysed tissues 
and in vivo imaging. Luciferase activity, 
normalized to the amount of total protein, 
was present specifically in adipose tissue 
at high levels with undetectable levels in other tissues, other than intestine 
 incorporated as determined by real 
time PCR analysis (data not shown); 
similar data were obtained for the other 
line. Figure 27: Luciferase regulation 
recapitulates leptin regulation in leptin-
luciferase animals 
Luciferase activity recapitulates regulation of 
leptin. The relative expression of luciferase 
versus leptin was compared among fed, 
fasted, and ob/ob animals. (Lower) 
Endogenous leptin expression levels from 
fasted, fed, and ob/ob animals were 
measured by Taqman real time PCR 
normalized to cyclophilin levels. (Upper) 
Luciferase activity of adipose tissue lysates 
from fed, fasted, and ob/ob animals 




(Figure 26A and B). It is not clear if the small signal of luciferase expressed in 
this tissue is in epithelial cells or in resident adipocytes.  
 
Figure 28: Regulation of luciferase upon high fat feeding in leptin-luciferase animals 
Luciferase and leptin mRNA levels of leptin-luciferse animals fed on a high-fat diet versus normal 
diet. (Upper Panel) Animal-to-animal comparisons of leptin mRNA versus luciferase levels in high 
fat treated animals (Lower Panel) 
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To confirm that the leptin-luciferase transgene was correctly regulated 
quantitatively, it was next tested whether luciferase expression was correlated 
with leptin mRNA levels in obese and lean animals. Leptin levels are highly 
correlated with cellular lipid content and its mRNA levels can vary hundreds of 
fold among fasted vs. obese animals (Maffei et al., 1995a). Relative expression 
of luciferase vs. leptin was compared among fed, fasted and ob/ob visceral fat 
pads. There was a hundred fold greater level of luciferase activity in extracts from 
ob/ob adipose tissue vs. extracts from fasted animals, which fully recapitulated 
the mRNA levels for endogenous leptin expression (Figure 27). These results 
were also confirmed in vivo using a CCD camera to monitor luciferase activity. 
(see Regulation of leptin gene expression chapter) Another evidence for 
correlation between luciferase levels and leptin mRNA levels came from high-fat 
feeding experiments. Fold induction of leptin gene expression in high-fat fed 
leptin-luciferase animals versus chow-diet fed animals was highly similar to that 
of luciferase levels. In addition, leptin mRNA correlated tightly with luciferase 
levels within subjects, ie. fatter animals having higher luciferase levels (Figure 
28).  Same fold inductions have been observed also in luciferase mRNA levels, 
which suggest that luciferase expression in the leptin-luciferase mice depends 
mostly upon transcriptional regulation (Data not shown).  
It should be noted that SVF fraction does not express leptin. 
Preadipocytes express leptin when differentiated to adipocytes. For this reason, 
use of leptin-luciferase animals provides a robust tool to track possible adipocyte 
progenitor cells and differentiation ability into mature adipocytes. Since leptin 
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correlates very well with the amount of lipid stored, the signal increases over time 
as the differentiated adipocyte accumulate more and more lipid (Figure 26C). 
Isolation of adipocyte progenitor cell using markers 
WAT is composed of multiple cell types including adipocytes, vascular 
cells and populations of fibroblast like cells that 
have not been well characterized (Cinti, 2005). 
To identify potential adipocyte progenitor cells, 
the stromal-vascular fraction (SVF) of wild type 
WAT was isolated (Rodbell, 1964) and FACS 
was performed to isolate distinct cell populations 
based on the differential expression of well 
characterized cell surface markers expressed by 
stem cell populations in other tissues. The cell 
sorting strategy that was used in these studies is 
shown (Figure 29) and described below.  Briefly 
lineage markers (Lin) and CD34, CD24 and Sca1 
are used to isolate the progenitor cell fractions. 
Among these markers, CD34 was previously 
suggested to be enriched in adipocyte progenitor 
cells (Miranville et al., 2004). CD24 and Sca1 were both implicated to have roles 
in stem cell biology as shown by previous studies (Lian et al., 2007; Okada et al., 
1992; Rao et al., 1995; van de Rijn et al., 1989). 
Figure 29: Scheme for FACS 
analysis of SV fraction 
The scheme for the FACS 
analysis is shown as a 
dendrogram of the hierarchy 
developed for cell sorting. The 
percentage yield of each 
population compared to the 
starting number live single cells 




The FACS strategy was used to enrich for adipocyte precursors that were 
fully competent for adipogenesis in vitro. First, endothelial cells and 
hematopoietic cells were depleted from the SVF based on staining of CD31, 
CD45, and Ter119, generating a Lineage negative (Lin-) population. Second, the 
cell populations depleted of the lineage markers were separated based on 
staining for CD34 and CD29, as described above. The Lin-:CD34+:CD29+ 
subpopulation was further separated based on staining for stem cell antigen 1 
(Sca-1) and CD24 (Shackleton et al., 2006; Spangrude et al., 1988; Wilson et al., 
2007). 
 
Figure 30: In vitro differentiation of adipocyte progenitor fractions 
The sorted CD24+, CD24−, and CD34−
  The Lin-:CD29+:CD34+:Sca-1+ population comprises approximately half 
of the cells present in the SVF (53.5%), but only a small population of cells also 
 cells and unsorted SVF were cultured and induced to 
differentiate with IBMX, glucocorticoid, and insulin. The cells were then cultured for 12 days prior 
to staining with oil red O. Macroscopic (upper panel) and microscopic (lower panel) views of the 
oil red O-stained dishes are shown (upper panel). 
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expressed CD24 with the total number of Lin-:CD29+:CD34+:Sca-1+:CD24+ 
(CD24+) cells constituting in total ~0.08% of the cells in the SVF (Figure 29). 
As the first step, these cell populations were tested based on their 
differentiation ability in vitro. CD24+, Lin-:CD29+:CD34+:Sca-1+:CD24- (CD24-) 
and Lin-:CD29+:CD34- (CD34-) subpopulations can differentiate into adipocytes 
in vitro using the standard protocol. After exposure to an adipogenic cocktail in 
vitro both populations, CD24+ and CD24-, developed into adipocytes with large, 
unilocular lipid droplets that stain with Oil Red O (Figure 30). Similar 
differentiation levels were found for both the CD24+ and CD24- subpopulations 
when insulin alone was used for in vitro differentiation (Data not shown). Note 
that while both CD24- and CD24+ populations could differentiate into adipocytes, 
the CD34- cells did not differentiate in vitro. These data showed that the FACS 
strategy that was employed had indeed enriched for adipocyte precursor cells. 
In vivo adipogenic ability of different SVF fractions 
 Previous data suggested that the adipose tissue of lipodystrophic animals 
may provide a microenvironment that is conducive to support the proliferation 
and survival of preadipogenic cells. Furthermore, leptin-luciferase animals 
provides the tool to monitor the ability of the CD24+ cells to develop into 
adipocytes, since the expression of luciferase in these mice is restricted to 
mature adipocytes within adipose tissue. Luciferase activity can be followed 
noninvasively in vivo by imaging with a CCD camera. Since cells of the SVF do 
not express the luciferase reporter, transplant of donor cells from the leptin-
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luciferase BAC transgenic mice allows to follow the development of mature 
adipocytes (as marked by luciferase activity) from the donor cells noninvasively 
in vivo. 
 
Figure 31: CD24+ cells reconstitute adipose tissue in lipodystrophic animals 
Luciferase imaging of adipocyte differentiation in the A-Zip transplantation model at indicated time 
points after injection of 50,000 donor cells from the CD24+, CD24−, or CD34−
 SVF cells from leptin-luciferase mice were isolated, FACS sorted and 
injected in the fat depots of A-Zip mice. Mice injected with the CD24
 cell populations. 
+ cell 
population derived from leptin-luciferase animals expressed luciferase in the 
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injected depot beginning at 2 weeks after injection with the expression of 
luciferase gradually increasing through the end of the 12 week time course. In 
contrast, injection of other cells did not yield high luciferase expression levels. 
This result suggested that the CD24−
 
 subpopulation is capable of adipogenesis in 
vivo but that the differentiation or proliferative potential of these cells is limited 
(Figure 31).  
Figure 32: Injection of CD24+ fraction corrects hyperglycemia and hyperinsulinemia in 
lipodystrophic animals 
A) Plasma (glucose) from A-Zip mice injected with the CD24+, CD24−, CD34−, or SVF cells, as 
well as WT and A-Zip controls. Results are shown as mean ± SEM. Correction of blood glucose 
by the CD24+ population is significant (p < 0.05) at week 2 and remains significant through the 12 
week experimental endpoint (n = 5). Results are shown as mean ± SEM. 
B) The plasma (insulin) at the 12-week endpoint of A-Zip mice that were injected with the CD24+, 
CD24−, or CD34− cell populations and noninjected wild-type and A-Zip controls is shown. Results 
are shown as mean ± SEM; *, p < 0.05 (n = 5). 
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 A-ZIP lipodystrophic animals are extremely hyperinsulinemic and 
hyperglycemic, which can be ameliorated by leptin treatment or adipose 
transplantation. If the cells are differentiating into functional adipocytes, the 
expectation would be that CD24+ injected animals will show amelioration of high 
glucose and insulin levels. For this reason, plasma glucose and insulin levels in 
A-Zip mice injected with the CD24+, CD24−, or CD34− cell populations were 
compared to noninjected A-Zip and wild-type control animals. Blood glucose was 
normalized after injection of the CD24+ population into the A-Zip animals in those 
animals where an adipose depot had formed. None of the other cell populations 
showed this capacity (Figure 32). The decrease of blood glucose levels was 
significant within 2 weeks of injection and was sustained for 12 weeks. Plasma 
insulin levels also were normalized in these CD24+-injected animals (Figure 32).  
These data indicate that the CD24+ cells generate functional WAT when injected 
into the WAT depot of A-Zip mice. 
Discussion 
This section introduces a novel way of identification of the unknown 
adipocyte progenitor cell population in vivo. Through FACS analysis, these 
studies demonstrate that primary cells from the adipose tissue stromal fraction 
can proliferate and differentiate into functional, mature adipocytes to reconstitute 
a fully functional adipose depot in vivo, which is enough to ameliorate 
lipodystrophic phenotype.  
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 One critical aspect of the study is the identification of A-Zip lipodystrophic 
mice as hyperadipogenic/hyperproliferative model.  WAT of A-Zip animals 
showed increased expression of early markers of adipocyte differentiation and 
high rates of proliferation, suggesting that presumptive WAT provides a niche 
conducive for promoting early events in adipogenesis. Indeed, CD24+ cells, 
when injected into wild type adipose depots, do not give rise to new adipocytes, 
which can be explained by the quiescence of the adult adipose depots (data not 
shown) (Greenwood and Hirsch, 1974; Greenwood et al., 1974). In this regard, 
A-ZIPs provide as the injection environment for identification of the CD24+ 
progenitor cells, making them a rare useful model for same type of studies. 
 Another important implication of this work is that CD24+ cells can produce 
metabolically functional adipocytes, secreting the adipokines to ameliorate 
lipodystrophic phenotype. It has previously been shown that the transplant of 
normal adult WAT into A-Zip mice is required for correction of their insulin 
resistance and hyperglycemia (Gavrilova et al., 2000). This also sets a 
preliminary model for treatment of lipodystrophy. The same type of cells, if they 
exist in humans, can be used as a stable source of fat cells in lipodystrophic 
patients, providing a constant source of leptin and other adipokines. 
The identification of an adipocyte precursor cell population provides a 
means for identifying tissue factors in wild-type and lipodystrophic WAT that 
regulate adipocyte proliferation and differentiation. Furthermore, the availability of 
the leptin-luciferase mice as donors in the A-Zip transplant assay, which allows 
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the noninvasive monitoring of adipogenesis in vivo, should facilitate the 






Embryonic Development of Adipose Tissue 
Up to this date, embryonic development of adipose tissue in rodents has 
not been fully characterized. One caveat to study adipose tissue development is 
that the adipocyte and lipid markers are thought to be expressed after the 
accumulation of lipids. However, it is very likely that the adipocyte character and 
commitment occurs before the accumulation of lipids. In this regard, lipid markers 
cannot be used to localize where adipose tissue develops. In this section, 
location of adipose tissue is determined using a leptin-luciferase transgenic 
animal (Birsoy et al., 2008). Identification of location of the developing adipose 
tissue helped to study the gene expression and morphology of these tissues.  
Results 
Location and Morphology  
In order to study the embryonic development of adipose tissue, the first 
step is finding the location of adipose tissue development. As explained above, 
the location cannot be determined using lipid markers. In parallel, early markers 
of adipogenesis usually have significant roles in other cell differentiation 
processes, so commonly expressed in other places. For instance C/EBPs have 
roles in hematopoiesis (Jones et al., 2002).  Many KLF factors have roles in 
epithelial cell differentiation (Katz et al., 2002; Swamynathan et al., 2007; Zheng 
et al., 2009). In addition, there is almost no distinct morphology for “lipidless” 




Figure 33: Embryonic development of adipose tissue 
Leptin-luciferase animals were sacrificed at the indicated embryonic time points. Embryos were 
imaged for assessing the location of possible adipose tissue structures. 
The tool to study adipose tissue development came from a leptin 
luciferase animal (see previous section) (Figure 26), where luciferase is 
expressed in context of leptin regulatory sequences. Since leptin expression is 
highly fat specific, any luciferase signal during embryogenesis is also thought to 
be fat specific. Indeed, during development, luciferase signal can be detected in 
leptin-luciferase mouse embryos (Figure 33). The signal is extremely low and the 
animals should be exposed 10 minutes as opposed to 30 second exposure of an 
adult leptin-luciferase animal. However, even this low level expression is enough 
to detect the exact localization of the possible adipose tissue development sites. 
Luciferase can be detected in E16.0 embryos and no E15.5 embryo showed any 
detectable luciferase signal. The source of the luciferase signal emanates from 
the subcutaneous areas as well as interscapular areas, consistent with the adult 
adipose locations (Figure 33). One advantage of finding the locations of 
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developing adipose tissue sites is that these sites can now be dissected and the 
morphology and gene expression patterns be studied. 
Microscopic analysis of AT development between E16.5-P0 
Since the location of developing adipose tissue sites can be dissected, 
next these small tissue fragments were analyzed by using whole-mount 
technique under confocal microscopy. Vascularization, lipid accumulation and 
overall morphology have been checked using different dyes as explained below. 
 
Figure 34: Morphology of adipose tissue during development 
Figure shows the fat accumulation and vascular structure of adipose tissue during development. 
Tissues were dissected using dissection microscope. Green shows the vasculature, red shows 
lipid and blue shows the nuclei staining. (A) Panel B shows the real time PCR analysis of leptin 
through embryonic development. Note that the lipid accumulation is very correlative with the 
leptin expression. Also note that lipid starts to accumulate after birth. 
85 
 
The results show that lipid accumulation does not happen until after birth. 
Just after birth, lipid starts to accumulate very rapidly in the adipocytes as 
assessed by lipid-tox staining at P0. Real-Time PCR analysis of leptin shows that 
big increases for leptin expression occur rapidly after birth around P2-P5, which 
is consistent with the fact that lipid accumulation is highly correlated with the 
expression of leptin (Figure 34). In addition, note that, real time PCR analysis 
shows extremely low leptin expression levels before birth, which suggests that 
the CCD camera system is very sensitive to luciferase signal detection. 
Gene expression analysis of adipose tissue development 
Embryonic adipose tissue fragments can be dissected and analyzed as 
explained above. As a part of the characterization, developing adipose fragments 
were digested by collagenase and sorted in order to analyze the percentage of 
different adipocyte populations. Of importance, P1 (CD24+,CD34+) population 
showed significant change during development. Preliminary results show that this 
population, which was identified to be the adipocyte progenitor cell population, 
increases around E18.5 just before birth (data not shown). 
Microarray analysis was also performed on the developing subcutaneus 
adipose tissue. Figure 35 shows the change in early genes and late genes during 
development of adipose tissue. Note that, compared to 3T3-L1 differentiation, 
this data is in vivo and leptin expression can be detected at high levels. 
Interestingly, late genes such as PPARƔ, CEBPa, FABP4, Adipsin and 
Adiponectin were all found to be expressed at their maximum level around E18.5, 
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before the start of lipid accumulation. On the other hand lipid accumulation 
seems to be very consistent with the leptin expression levels (Figure 35). Early 
genes such as KLF4, Pref1 and KLF5 are downregulated starting E16.5 to P0, 
suggesting that early adipogenic processes along with the clonal expansion is 
mostly completed before birth. 
 
Figure 35: Gene Expression Analysis of Developmental Time course 
Late genes such as PPARƔ, CEBPa, Adiponectin and Adipsin reach their maximum levels 
around P0. On the other hand leptin levels plummet with lipid accumulation after birth. Many early 
genes were found to be downregulated through development. 
 
Discussion 
 In summary, above data provides the first thorough characterization of 
embryonic development of adipose organ in rodents. This data suggests that in 
vivo adipose tissue development may be different than in vitro adipocyte 




Figure 36: Distinct transcriptional networks regulating adipocyte differentiation in vivo  
 During development, luciferase signal can be detected in three major 
locations; posterior subcutaneous, anterior subcutaneous (neck) and 
interscapular region. Subcutaneous regions are consistent with the localization of 
white adipose tissue in adults. However, interscapular signals suggest that these 
signals may be coming from developing brown adipose tissue. One caveat of 
identifying if the signal is coming from brown or white adipose tissue is that, 
brown adipose tissue contains white adipocytes.  
Furthermore, interscapular region contains a separate white adipose tissue 
located laterally to the brown adipose tissue. This suggests that close proximity 
and heterogenous nature of brown fat may result in the luciferase signal in the 
interscapular region. In addition, since leptin is a signal for energy stores, leptin’s 
presence in brown adipocytes seem physiologically irrelevant. However, it is 
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possible that brown adipocytes may express low amounts of leptin due to the 
presence of lipid, as suggested by previous reports (Cinti et al., 1997; Oliver et 
al., 2000). 
 Our data suggest that there are several distinct networks of genes that are 
expressed during fat cell differentiation. One group includes the genes that are 
upregulated during embryogenesis till the birth of the animal (Figure 36). This 
group of genes contains adipocyte-related transcription factors such as PPARƔ, 
C/EBPα and also secreted factors such as adiponectin and adipsin. The second 
group of genes is upregulated with the accumulation of lipid. These genes 
include leptin and other mostly uncharacterized genes. An important implication 
of this analysis is that genes that are previously thought to be associated with the 
adipocyte phenotype based on in vitro studies seem to be regulated 
independently of the accumulation of lipid. On the other hand genes in the latter 
cluster, including but not limited to leptin, are expressed correlative with the lipid 
accumulation. Clustering analysis of genes in this microarray data may lead to 
the identification of novel genes/pathways having roles in adipocyte function and 




CHAPTER 6:  
Regulation of Leptin gene expression 
In mammals, homeostatic control of adipose tissue mass is regulated by 
leptin, which functions as the afferent signal in a negative feedback loop to 
maintain constancy of body fat content. Leptin is secreted in proportion to 
adipose tissue mass and in turn 
regulates food intake and energy 
expenditure. A fuller understanding of 
the elements of this system could have 
important implications for the patho-
physiology and treatment of obesity. 
Adipocytes secrete leptin in proportion 
to their size meaning that as they 
accumulate more lipids, they secrete more leptin (Figure 37). This suggests the 
possibility that cellular lipid content is sensed and that a fuller understanding of 
the mechanisms controlling leptin gene expression could lead to the delineation 
of a lipid sensing mechanism in fat cells and possibly other cell types. To 
discover this mechanism, there is need to search for the region in the leptin gene 
promoter that controls the quantitative expression of the leptin gene; ie the 
elements that confer increased leptin expression with obesity and decreased 
expression after weight loss (see below). Since leptin is expressed at much 
higher levels in fat tissue in vivo than in vitro where it is not regulated in 
proportion to cellular lipid content, these studies require that gene expression be 




monitored in vivo.  This part of the thesis deals with the regulation of leptin gene 
expression via a BAC transgenics approach. 
Results 
Leptin expression can be studied using a BAC transgenic model 
The leptin gene is relatively unusual because it is expressed at much 
higher levels in vivo vs. in vitro in differentiated 3T3-L1 or F442 cells(Mandrup et 
al., 1997b).  Since these cell lines abundantly express the master regulator 
PPARƔ, CEBPs, and their targets, this suggests that the adipocyte specific 
expression of leptin is controlled by a different transcriptional mechanism.  Thus 
the delineation of the basis for the tissue specific expression of the leptin gene 
could reveal an in vivo specific developmental program.  The fact that leptin is 
only expressed at high levels in vivo has necessitated that the leptin promoter be 
studied using transgenic mice.  In order to confer all the regulatory regions, BAC 
transgenic mouse lines that express luciferase under the control of overlapping 
leptin regulatory sequences were generated. 
 Luciferase expression can be quantified in vitro as well as in vivo using a 
CCD camera (Greer and Szalay, 2002b). Thus, DNA sequences responsible for 
these regulatory processes can be generated by generating a series of promoter 
deletions and then monitoring luciferase expression 1) in different tissues, 2) in 
ob and fasted mice, 3) during development and 4) in response to hormones and 
drugs. It should be noted that same DNA sequences may be responsible for 
some or all of the different transcriptional responses the leptin gene exhibits.  
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The net result of these studies will be to localize one or more DNA sites 
responsible for conferring an ability of the leptin promoter to respond to intrinsic 
and extrinsic signals.   
 
 
Figure 38: Leptin gene structure 
Leptin regulatory elements are in -22kb to -18kb region 
Gene regulatory elements are often found at a great distance from 
transcription initiation sites (Chandler et al., 2007; Choi and Engel, 1986a; 
Murisier et al., 2006).  For this reason and because there is no prior knowledge 
of the sites of the gene regulatory elements that control leptin expression in vivo, 
we began by making BAC transgenic mice in which the luciferase was inserted 
into the second exon of the leptin gene at the site of the ATG initiation codon 
(Figure 38A). Two overlapping BACs were modified in this manner using 
homologous recombination in bacteria as previously described (Gong et al., 
2002).  The first BAC extended from –22 to + 140 kB and the second extended 




Figure 39: -22kb - +18kb construct is enough for fat-tissue specificity and fat-sensing 
regulation of leptin 
Images on the left side show the luciferase activity of the corresponding leptin-luciferase BAC 
transgenic line at different metabolic conditions. Each line was mated to ob animals to get obese 
luciferase animals or fasted. Imaging was done using IVIS lumina CCD camera using ob, fed and 
fasted mice. 
Middle panel shows tissue expression of luciferase of the corresponding leptin-luciferase BAC 
transgenic line. Briefly, each tissue was dissected and lyzed and luciferase activity was asssesed 
using a luminometer. 
Right panel shows the fat sensing regulation of the corresponding line upon fasting and obesity. 
Fat tissue was dissected from 5 animals for fasted, obese and fed group and luciferase activity 
was measured in fat using a luminometer, normalized by protein concentration. This result is 
consistent with the imaging experiments. (Left Panel) 
These BACs were injected into fertilized eggs from C57BL/6J mice and 
founder mice were bred to generate F1 animals.  The animals generated using 
the BAC that extended from –22 to +140 kB were characterized first.  Protein 
extracts were made from a variety of tissues and analyzed for luciferase activity 
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in the presence of luciferin the standard substrate.  These studies showed very 
high luciferase levels in adipose tissue with undetectable levels in the other 
tissues that were tested.  In this and subsequent experiments, the luciferase 
activity was related to the amount of total protein (Figure 39). 
The relative expression of luciferase vs. leptin was also compared among 
fed, fasted and ob mice.  The latter were made by mating the Leptin-Luciferase 
BAC transgenes to ob/+ animals followed by intercrossing.  In this case, there 
was a several hundred fold greater level of leptin RNA and luciferase in the ob 
vs. fasted animals (Figure 39). 
The second set of transgenic animals made using the BAC that extended 
from –160 kB to + 18 kB also gave the same results.  These animals also show 
fat specific luciferase expression with a marked decrease after fasting and a 
marked increase when the animal is mated to ob/ob animals.  Since both BACs 
show coordinate regulation of leptin and luciferase over the same dynamic range 
these data narrow the sequences required for fat specific and quantitative 
regulation to between –22 kB and +18 kB of the gene. A -22kb-18kb animal was 
also made to ascertain the region. Indeed this transgenic animal showed 
consistent results with the previous animals (Figure 39). 
Luciferase can also be quantified in vivo by imaging anesthetized animals 
using a CCD camera(Greer and Szalay, 2002a; Welsh and Kay, 2005).  In vivo 
imaging allows one to follow luciferase levels in the same animal over time 
(without having to sacrifice mice) and also provides the basis for experiments to 
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follow the fate of adipocyte stem cells as explained before. To monitor in vivo 
luciferase activity, animals were anesthetized with isoflurane, and injected with 
15 mg/ml D-Luciferin (Xenogen, Alameda, CA) i.p.  Luciferase activity was 
imaged using the IVIS Lumina machine (Xenogen) and the data were analyzed 
using the Living Image software (Xenogen)(Franke-Fayard et al., 2006).  Of 
importance, the software integrates signal over surface area of tissue so 
approximately the same amount of adipose tissue is assayed in comparisons of 
fed, fasted and ob mice. 
This data provided the basis for the characterization of a series of 
promoter deletions to fine map the cis regulatory elements of the leptin gene, as 
a starting point for identifying interacting trans-factors. 
Ultraconserved sequences around leptin gene  
As a general rule of thumb for studying promoters of genes, researchers 
make use of comparative DNA sequence analysis to identify conserved 
sequences in the vicinity of the gene of interest to guide the making of promoter 
deletions. Leptin gene has evolved with emergence of vertebrates. However, its 
function as a lipostat sensor seems to have evolved with endothermic animals, 
especially mammals. For this reason, vicinity of leptin gene has been checked for 
high conservation among mammals. 
  Fortunately, the chromosomal region in the vicinity of the ob gene has 
been extensively sequenced in a number of organisms.  Genomic sequences 
around leptin gene from several mammalian animals were aligned by using 
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VISTA program for finding conserved regions, which might be candidates for 
possible transcription binding sites.  Genomic sequences have been retrieved 
from UCSB genome browser.  This analysis identified 2 ultraconserved regions, 
one being in the -17kb upstream of leptin, the other being in the first intron 
(Figure 40).   
 
Figure 40: Conservation of sequences around leptin gene 
Data has been retrieved using UCSC genome browser. 0 indicates the TSS of leptin. Note the 
high conservation between -17kb and +3kb. 
 -22-0 kb regulatory sequences carry fat specificity and fat sensing 
 Since, the 5’ upstream sequence of a gene is usually regarded as the 
most critical region for transcriptional regulation, 22kb upstream region of the 
leptin gene were used to make transgenic animals as the next step. Note that 
this construct does not carry any introns, since the luciferase is inserted in the 
first exon.  -22-0kb transgenic animals, carrying 22kb upstream region, conferred 
fat tissue specific expression and the expression is regulated by fasting and 
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obesity (Figure 41). On the other hand; -762bp-0 transgenic animals, carrying 
762 bp upstream sequence, showed no fat tissue specificity in all two founders, 
both having ovary/testis specific luciferase expression (Figure 42). One issue 
with the –22-0kb animals is that the quantity of luciferase expression was 50-100 
times less compared to the transgenic lines where luciferase was inserted into 
the translation start site, namely -160-18kb, -22-140kb and -22-18kb (Data not 
shown). This low expression can be ameliorated by adding a chimeric intron; 
however it might also suggest the existence of an enhancer region in the intron. 
 These data suggest that 22kb upstream sequence is enough to drive fat-
specific expression and lipid sensing properties of leptin. Further, 762bp 
promoter is not enough to drive fat-specific regulation of leptin. 
 
Figure 41: Luciferase expression in -22kb-0 Luciferase animals 





Figure 42: Luciferase expression in -762bp-0 Luciferase animals 
Expression of luciferase in ovaries and testis was assessed by in vivo imaging using an IVIS CCD 
camera. No expression was observed in the fat tissue 
-17kb conserved region histones are hyperacetylated and hyper 
monomethylated 
 Patterns of histone modifications influence transitions between chromatin 
states and the regulation of transcriptional activity. Different histone marks have 
been proposed to have different effects on transcriptional activity. Some of these 
marks are enriched in enhancers, and some in promoters as some are 
associated with active transcription whereas others are associated with 
repression. There are many reports regarding the histone marks at distant 
enhancers by several different groups.  H3K4 methylation is often linked with 
transcriptional activity in many contexts. Specifically, H3K4 trimethylation is 
associated with promoter regions of almost all active genes (Choi and Engel, 
1986b). Recently several groups also found associations between active 
enhancer regions and H3K4dimethylation and/or H3K4monomethylation 
(Bernstein et al., 2006; Robertson et al., 2008; Roh et al., 2007). In addition, 
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there seems to be a direct correlation between active transcription and histone 
acetylation (Ruthenburg et al., 2007).  In contrast, H3K27 trimethylation is 
associated with promoters of inactive genes. In an earlier study, Litt et al. 
performed a “chromosome walk” on DNA sequences for the beta globin gene, 
testing previously known to be active or inactive regions, by performing Chip 
assays using antibodies against H3K4 marks (Litt et al., 2001). 
Since the elements conferring leptin regulation is thought to be between -
22kb and -762 bp region, it was hypothesized that the only ultraconserved DNA 
stretch in this region may be functionally important. For this reason, chromatin 
immunoprecipitation analysis has been performed around the -17kb region. 
Basically, fat tissue was fixed, lyzed and nuclei were isolated. Nuclei later were 
lyzed and sonicated and immunoprecipitated with the corresponding antibodies. 
H3K9Ac and H3K4monomethyl antibodies were used for immunprecipitation. For 
analysis, sybr green real time PCR analysis was used. PCR fragments with 800 
bp intervals were designed around -17kb region and input and IP samples were 
analyzed by Real Time PCR. The results show that -17kb region was indeed 
enriched for H3K9Ac and H3K4monomethyl marks (Figure 43). Both of these 
marks before were shown to be enriched in enhancer regions using whole 




Figure 43: Chip analysis of -17kb conserved region 
 
Figure 44: Deletion analysis of leptin-Luciferase BAC transgenic animals 
Table shows the current state of the characterization of BAC transgenic constructs.  
Fat specificity shows if the corressponding luciferase-BAC transgenic line recapitulates fat-
specific expression of  leptin. 
Expression level shows the luciferase expression of the corresponding BAC transgenic animal. 
“?” indicates that the work is in progress. “H” indicates high expression of luciferase as assessed 
by in vivo imaging using IVIS CCD camera. “L” indicates low expression.  
Fat sensing shows if luciferase expression in the animals recapitulate the lipid-sensing regulation 
of leptin. “Y” indicates that the animals recapitulate the fat sensing property of leptin. This is 




Further deletion analysis of leptin promoter 
As the next step, more deletion constructs were made to refine the region.  
As shown in figure 44, deletions from -17kb down to -762bp constructs in the 
context of +18kb downstream have been made, assuming that the element is 
between -22kb to -762bp region. Surprisingly -762bp-18kb (also 762bp-8kb) 
transgenic animals conferred fat tissue specific expression of luciferase. 
Furthermore, this expression was at high levels. Note that only -762 bp region 
alone was not enough to confer any fat-specific expression. These results 
suggest that leptin regulation might be redundant or a complex regulation is 
taking place which will be discussed in the final discussion section (Figure 44). 
Search for trans-factors regulating leptin gene expression 
 One approach to find possible transfactors and mechanisms that regulate 
leptin expression is by using microarray analysis. DNA microarray represents a 
powerful tool in biomedical discoveries. Harnessing the potential of this 
technology depends on the development 
Leptin is adipocyte-specific such that when the adipose tissue is 
dissociated by collagenase digestion, the pelleted stromavascular fraction does 
not have any detectable leptin mRNA compared to adipocytes. The assumption 
and appropriate use of data mining and 
statistical tools.  Leptin is regulated differently in different metabolic states. This 
range of regulation is extremely helpful for microarray analysis, since it will 




would be that any factor that confers fat specificity should be enriched in 
adipocytes. For this reason, a DNA chip analysis was performed to identify genes 
that are enriched in the adipocyte fraction compared to stromavascular fractions. 
Interestingly, only a handful transcription factors were enriched in adipocyte 
fraction. These transcription factors include, CHREBP(MLXIPL), which  is known 
to be a glucose sensor transcription factor that is also expressed in several other 
organs such as liver, (Dentin et al., 2005; Mason et al., 1998) PPARƔ/RXR, 
which is thought to be the master regulator of adipogenesis, C/EBPα, a gene that 
was shown to regulate adipogenesis and leptin expression in vitro, (Mason et al., 
1998) SREBP, a cholesterol sensing transcription factor (Kochan, 2003; 
Stelmanska et al., 2005) and DBP, a zinc finger factor with relatively unknown 
function (Mikhailov et al., 2008) (Figure 46). 
Since -762bp-8kb region which includes 762 bp promoter and 8kb first 
intron, confers high expression in adipose tissue, the conserved regions and 
possible transcription factor binding sites were analyzed. Conserved region in 
762 bp promoter contains a C/EBP binding site along with Cdx/USF binding 
sites. Ultraconserved region in the first intron contains C/EBP binding sites along 
with GATA binding sites, which were before shown to be important in 
adipogenesis. These transcription binding sites might provide useful with regard 






The in vivo analysis of leptin regulation suggests that leptin regulation is 
more complex than it was previously thought using in vitro systems (Chen et al., 
1999; Hollenberg et al., 1997; Mason et al., 1998). -762 bp promoter, which was 
shown to contain elements for C/EBP factors, is not enough to confer leptin 
regulation (Mason et al., 1998). The cis-elements possibly involve a fat-specific 
regulatory domain along with an enhancer domain. The possible binding sites 
found in 762 bp promoter and ultraconserved sequence in the intron for C/EBP 
and GATA suggest that these transcription factors which were before shown to 
be expressed in adipocytes might indeed have roles in regulating fat-specific 
expression of leptin. However, the fact that these transcription factors are also 
expressed in 3T3-L1 adipocytes, cannot explain why leptin is not expressed in 
this system. It is likely that a novel combination of transcription factors are lacking 
in 3T3-L1 adipogenesis. These issues will be discussed more thoroughly in the 
final discussion chapter. 
Dissecting cis-acting regulatory sequences using genomic clones and 
reporter genes has been performed mostly in cultured cells and in vitro systems 
rather than animals because transgenic methods are relatively inefficient, costly 
and regulatory regions for proper expression in vivo usually lie large distances 
from the targets and cannot be included in conventionl plasmids. A significant 
advance came from the discovery of modification of bacterial artificial 
chromosomes using BAC recombineering (Warming et al., 2005).  This method 
has been used by several groups to identify cis-acting regulatory sequences and 
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locus control regions (Carvajal et al., 2001; Huang et al., 2000; Jamsai et al., 
2003; Kaelin et al., 2004; Lehoczky and Innis, 2008; Oginuma et al., 2008; 
Smale, 2003; Yu et al., 1999). Dissection of cis-acting transcriptional regulatory 
elements using reporter genes in BAC transgenic mice can provide insights into 










Figure 45: Conserved sequences and transcription binding sites in -762bp-+8kb sequence 
 





Chapter 7:  
Practical Applications of Leptin-luciferase Animals 
Introduction 
Leptin-luciferase BAC transgenic mouse line expresses luciferase under 
the control of leptin promoter elements, making it possible to assess the activity 
of the leptin gene in vitro biochemically, and in vivo by imaging of luciferase 
activity with a CCD camera (Figure 26-28) (Contag and Bachmann, 2002). Since 
leptin level is highly correlated with adipose tissue mass,(Ahima and Flier, 2000; 
Frederich et al., 1995; Jernas et al., 2006; Maffei et al., 1995a) the leptin-
luciferase animal model also provides a novel means for assessing adipose 
tissue mass non-invasively in vivo. Possible applications for this line include the 
delineation of the embryonic origins of adipose tissue, as discussed in the 
previous chapters, and screens for modulators of adipose tissue mass. In 
addition half-life of luciferase (~3 hours) enables to study relatively short changes 
in gene expression (Leclerc et al., 2000). In this chapter, this strain was 
employed to study the response of adipose tissue before and after either food 
restriction or leptin treatment. These experiments enabled the identification of a 
novel cellular program that allows the conversion of glycogen intermediates to 





 Fasting and refeeding induce dynamic responses in leptin-luciferase 
expression levels in adipocytes 
The level of luciferase was monitored in animals during a three day fast 
and after refeeding.  These experiments were performed in the same animal over 
time using the CCD camera. Luciferase activity fell gradually over the course of 
the fast and by three days there was a ~6-8 fold lower level of luciferase activity 
(Figure 47A). Luciferase activity returned to baseline by 6 hours after refeeding. 
Because 6 hours is not enough time to regenerate the adipocyte population, this 
extremely rapid recovery of the leptin-luciferase signal after refeeding suggested 
the possibility that lipid depleted adipocytes persist in adipose tissue after fasting.  
Consistent with this, histological analysis at the conclusion of the three-
day fast showed smaller adipocytes with a markedly lower cellular lipid content 
(Figure 47B). The identity of these cells as adipocytes was established by 
immunohistochemical staining with an antibody to aP2, an adipocyte specific 
marker (Figure 47B). However, note that there was residual lipid in some of the 
adipocytes after the fast, evident by significant luciferase activity and thus sought 
to identify conditions under which there was near complete depletion of cellular 




Figure 47: Time course luciferase activity in leptin-luciferase animals upon 
fasting/refeeding 
(a) Time course luciferase activity in leptin-luciferase animals upon fasting and refeeding. The 
level of luciferase in animals was monitored during a three day fast and after refeeding .  The 
data were collected for the same animal over time. (n=4)  Luciferase activity fell gradually over 
the course of the fast. After refeeding, luciferase activity  returned to baseline by 6 hours.  (Upper 
panel) Representative time-course images of fasted and refed animals are shown.  (Lower panel) 
Quantitation of in vivo signals by Living Image 3.0 software. (mean +/-SEM). (b)Histological and 
immunohistochemical analysis of adipose tissue of fasted mouse.  H&E staining  of wild-type (left) 
and fasted (middle) animals for comparison. Note that nuclei are approximately the same size. 
Immunohistochemical staining  of the adipocyte specific protein, aP2, in fasted animals (right).  






Figure 48 Body weight, food intake, serum leptin, serum insulin and serum glucose of 
acutely leptin deficient mice 
(A) Leptin treatment resulted in a rapid and sustained decrease in body mass relative to PBS 
control animals (blue squares). When exogenous leptin was withdrawn (leptin withdrawal, Right), 
free-fed animals (Leptin-FF, green circles) rapidly gained back lost weight while animals 
maintained at normocaloric intake levels (Leptin-NC, red triangles) rebounded more slowly. (B) 
Leptin treatment decreases food intake only while body mass is being lost after which time levels 
return to normal. Following leptin withdrawal, hyperphagia ensued in leptin-FF animals, while it 
was prevented in Leptin-NC mice in order to control for effects simply due to an increase in food 
intake. (C) Serum leptin levels were 20 fold elevated during leptin treatment and dropped 
precipitously following leptin withdrawal relative to PBS control animals (blue bars). In leptin-FF 
mice (green bars), levels were low for two days (WD Day 1 and WD Day 2), while in leptin-NC 
(red bars) mice, low serum leptin persisted for four days. Statistically significant differences are 
noted (*, P < 0.05 vs. PBS; #, P < 0.06 vs. PBS; **, P < 0.005 vs. PBS). (D) Serum insulin levels 
are 12 to 20 fold lower than PBS controls following 6 or 8 days of leptin treatment (*, P < 0.05 vs. 
PBS; **, P < 0.005 vs. PBS). Following leptin withdrawal, insulin rose in Leptin-FF mice while 
maintaining mice on normocaloric intake prevented any rise in serum insulin (†, P < 0.05 vs. 




 Leptin treatment induces near complete delipidation of adipocytes, 
conserving adipocyte specific protein expression 
Mice were treated with high dose leptin via subcutaneous pump for 8 
days. Leptin treatment led to a complete depletion of all visible body fat which 
was associated with the complete absence of luciferase expression (Figure 49). 
Histology of the adipose depot after 8 days of leptin showed a dense population 
of cells with little or no detectable cellular lipid. However, these lipid-depleted 
cells still showed high levels of the adipocyte-specific protein aP2 expression 
suggesting that after leptin treatment the adipose tissue was populated by lipid 
depleted adipocytes (Figure 49). 
 After eight days the leptin osmotic pumps were removed. Following 
withdrawal of exogenous leptin, animals fed ad libitum became markedly 
hyperphagic and body fat mass returned to pretreatment levels over the course 
of four days (Figure 48).  Luciferase levels were clearly detectable in animals 
post leptin withdrawal after one day; and after 4 days the luciferase signal 
returned to baseline levels (Figure 49). 
The data from leptin treated animals were consistent with data from fasted 
animals and suggested that under both conditions the adipose depot is 
composed of lipid depleted adipocytes. The data further suggest that leptin 
treatment leads to the complete depletion of cellular lipid providing a unique 
opportunity to study the molecular programs that are responsible for the repletion 




Figure 49: Leptin withdrawal experiment 
(a) In vivo imaging of leptin-luciferase animals upon leptin withdrawal. PBS (n=6) or leptin at 2.5 
µg/hour (n=5) was administered for 8 days by subcutaneous implanted osmotic pump. On day 8, 
leptin or PBS treatment was withdrawn by removing pumps under inhaled anesthesia. Animals 
were imaged before treatment, after 8 days of leptin treatment and daily for the 4 days following 
removal of leptin pumps. Leptin treatment resulted in a rapid and sustained decrease in leptin 
expression and fat depots relative to PBS control animals. Note that no significant luciferase 
activity was detected after leptin treatment.  After exogenous leptin was withdrawn, luciferase 
activity in adipose tissues from free-fed animals returned to original levels in 4 days. (Upper 
panel) Imaging results of representative animals form PBS and leptin treated groups are shown. 
(Lower panel) Quantitation of in vivo signals by Living Image 3.0 software indicates a dramatic 
suppression of luciferase by exogenous leptin treatment (mean +/-SEM). (b)Preservation of 
adipocyte identity during chronic leptin treatment. Leptin treatment results in near complete 
depletion of triglyceride droplets from white adipose tissue. White adipose tissue of mice treated 
for 8 days with leptin consists of dense islands of cells as assessed by hematoxylin and eosin 
staining (middle). Note for comparison that nuclei are the same size. Immunohistochemical 
staining demonstrated high levels of the adipocyte specific protein aP2 in the cytoplasm of high 
numbers of cells in de-lipidated white adipose tissue (right, brown, peroxidase positive material). 
Fat pads of leptin treated animals consisted almost entirely of adipocytes expressing high levels 
of aP2 protein, despite lack of preservation of typical adipocyte morphology. 
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 Recovery from Hypoleptinemia Increases Cellular Glycogen Prior to 
the Reappearance of Cellular Lipid  
 In order to study the cellular programs activated when fat mass is 
repleted, RNA was prepared from adipose tissue during leptin treatment and 
after 1-4 days post leptin withdrawal for use with oligonucleotide microarrays to 
follow the patterns of gene expression after leptin withdrawal. While preparing 
the RNA from these samples, we noted the appearance of large amounts of a 
white flocculent material after ethanol precipitation. This material had the gross 
appearance of glycogen. To confirm this, tissue glycogen levels were checked 
biochemically. On the first day post leptin withdrawal there was a massive 
increase in glycogen content in the adipose depot with a total glycogen content of 
1 % of the total wet weight of the tissue (Figure 50). Treatment of acutely leptin-
deficient white adipose tissue lysates with amyloglucosidase, an enzyme which 
specifically hydrolyzes glycosidic bonds (Keppler, 1974) liberated a large amount 
of soluble glucose, confirming the presence of high levels of glycogen. Periodic 
acid-schiff (PAS) staining of tissue sections showed dense staining in cells 
containing small lipid droplets confirming the presence of glycogen granules in 
adipocytes (Figure 50). The PAS stained material was further confirmed to be 
glycogen by pre-digesting tissue sections with α-amylase which eliminated PAS 
positive granules. Intense staining was visualized in a similar pattern to that 
shown previously for aP2 (Figure 50). 
The total glycogen content decreased over the ensuing 3 days by which 
time adipose tissue mass had returned to the same level as prior to treatment. 
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Histological analysis over this period indicated enlarging adipocyte lipid droplets 
in the same cells that showed PAS staining for glycogen (Figure 50). 
 
Figure 50: Accumulation of white adipose tissue glycogen during acute leptin deficiency 
(a) White adipose tissue glycogen content rose 30 to 60 fold in leptin withdrawal animals(green 
and red bars) relative to PBS controls (blue bars) following withdrawal of exogenous leptin 
treatment, as measured by glucose liberated by amyloglucosidase (*, P < 0.05 vs. PBS; #, P < 
0.065 vs. PBS). This increase occurred in both free-fed animals (Leptin-FF, green bars) and 
animals maintained at  normocaloric intake levels (Leptin-NC, red bars), and increased glycogen 
content persisted for 3 and 4 days in these groups, respectively. (b) Periodic acid-schiff (PAS) 
staining of white adipose tissue on withdrawal day 1 and withdrawal day3.  PAS staining on 
withdrawal day 1 indicated large amounts of cytoplasmic glycogen content in leptin-FF and leptin-
NC tissue sections (black arrows). This contrasted sharply with control PBS treated white adipose 
tissue. On withdrawal day 3, glycogen accumulation decreased in parallel to the accumulation of 
lipid. (red arrows) a-Amylase pretreatment of tissue sections eliminated PAS positive granules in 




Figure 51: Pathway of acetyl-CoA and glycerol generating enzymes upregulated by acute 
leptin deficiency.  
 Acute leptin deficiency induced the pathway of genes (blue ovals) necessary to synthesize 
cytoplasmic acetyl-CoA and glycerol from simple sugar precursors. Fold change for each gene on 
day 1 following leptin withdrawal is shown below each enzyme name for leptin-FF (left) and 
leptin-NC (right) mice with the associated P value immediately below each fold change value. 
Potential sources of carbon for acetate or glycerol synthesis are in blue text.  
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 The Transcriptional Program Associated with Recovery of Adipose 
Tissue Mass 
These data suggested that the repletion of cellular lipid content and 
adipose tissue is achieved via a glycogen intermediate in lipid-depleted 
adipocytes. To study this further, transcription profiles of adipose tissue were 
generated by analyzing RNAs at 6 or 8 days of leptin treatment and 1, 2, 3, and 4 
days after leptin withdrawal (Figure 47-48). To refine the analysis, RNA was 
prepared both from hyperphagic animals fed ad libitum after leptin withdrawal, i.e 
leptin-FF as well as from animals whose food intake was restricted to that which 
the animals ate voluntarily prior to leptin withdrawal, i.e leptin-NC animals 
(defined above). As an additional control, tissues from PBS treated animals were 
analyzed both before (day 6) and after (day 1 post-withdrawal) removal of the 
osmotic pumps. In all cases, RNA was labeled using biotin and hybridized to 
Affymetrix 11K oligonucleotide microarrays.  
Selection and k-means cluster analysis (Soukas et al., 2000) of 683 genes 
changing significantly across experimental conditions identified 14 statistically 
distinct patterns of gene expression. Analysis clusters induced specifically by 
acute leptin deficiency revealed an enrichment of genes associated with gene 
ontology (GO) terms related to carbohydrate metabolism (Figure 51). 
Specifically, many genes induced in adipose tissue during weight gain play a role 
in glucose uptake, glycolysis, and acetyl-CoA and glycerol synthesis. An acute 
decrease in circulating leptin level induced nearly the entire complement of 
genes necessary to increase simple sugar flux into the adipocyte, and 
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subsequently convert these sugars into cytosolic acetyl-CoA and glycerol for de-
novo fatty acid, triglyceride, and cholesterol biosynthesis (Figure 51). Average 
expression level for these mRNAs peaked on day 1 of acute leptin deficiency but 
remained elevated for four days following cessation of leptin treatment. 
Leptin withdrawal also induced the expression of genes required for the 
storage of cytoplasmic triglycerides including genes involved in the synthesis of 
glycerol such as glycerol-3-phosphate dehydrogenase mRNA (3 and 2.8 fold in 
leptin-FF and leptin-NC mice, respectively). This enzyme catalyzes the 
conversion of dihydroxyacetone phosphate, a glycolytic intermediate, into 
glycerol-3-phosphate (or vice versa). Triglyceride storage is also augmented 
during acute leptin deficiency by a 70% and 30% induction of glycerol-3-
phosphate acyltransferase (GPAT) in leptin-FF and leptin-NC animals, 
respectively.  GPAT catalyzes the esterification of glycerol-phosphate and fatty 
acids for storage in adipose tissue.  
Acute leptin deficiency specifically repressed four groups of genes that 
were induced or unchanged during chronic leptin treatment. These genes 
included both carnitine-palmitoyl transferase-I (CPT-I) and peroxisomal acyl-CoA 
oxidase (ACO) both of which are required for fatty acid oxidation. CPT-I, which 
enhances mitochondrial uptake of fatty acids for oxidation, is decreased in leptin-
FF and leptin-NC mice 3.0 and 1.9 fold, respectively. ACO, which catalyzes 
enzymatic fatty acid breakdown, is 2.7 fold repressed in leptin-FF mice and 1.3 
fold repressed in leptin-NC mice. White adipose phosphoenolpyruvate 
carboxykinase (PEPCK) mRNA, which would detract from acetyl-CoA 
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accumulation, was repressed 36 and 2.4 fold in leptin-FF and leptin-NC animals, 
respectively (Figure 51). 
Leptin withdrawal did not regulate the mRNA of genes involved in 
glycogen synthesis or glycogenolysis suggesting that the induction of glycogen 
synthesis is not regulated at the level of transcription (Figure 51). As discussed 
below, these data suggest that the genes required for glycogen synthesis 
continue to be expressed in adipocytes in the setting of weight loss and thus 
allow the accumulation of glycogen when food is consumed. Lipid synthesis 
genes are repressed after a fast and this glycogen then serves as substrate for 
the biosynthesis of triglyceride when the genes required for lipid synthesis are 
induced.  
Discussion 
 The cellular and molecular programs responsible for the repletion of 
adipose tissue mass after weight loss has not been fully elucidated. In this 
chapter, this issue was addressed using molecular genetics, physiologic and 
computational tools and show that weight loss after food restriction results in the 
partial loss of adipose tissue lipid while leptin treatment results in the persistence 
of adipocytes that are nearly completely depleted of their cellular lipid. It was 
further shown that the restoration of adipose mass acutely after re-feeding is 
associated with the production of massive glycogen deposition that temporally 
precedes the recovery of adipose tissue mass.  Finally, it was shown that acute 
hypoleptinemia activates a novel program of gene expression with the induction 
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of gene products that convert glucose and other simple sugars into glycerol and 
acetyl-CoA for triglyceride synthesis. 
Leptin expression is markedly reduced after a three day fast and its level 
of expression is restored nearly to baseline levels within 6 hours after refeeding. 
This rapid repletion of leptin expression is too rapid to be consistent with the 
possibility that there is apoptosis of adipose tissue followed by de-novo 
adipogenesis. Rather these data suggested that fat loss after food restriction 
results the depletion of lipid within adipocytes. This conclusion is supported by 
data from immunohistochemical staining of adipose tissue with an antibody to 
aP2, a fat specific gene,(Hunt et al., 1986) which is still expressed at high levels 
in adipose tissue after a fast, at a time when there are markedly reduced 
amounts of lipid. Eight days of leptin treatment caused an even more dramatic 
reduction of adiposity and histological analysis of adipose tissue of leptin-treated 
animals demonstrated dense nests of aP2 expressing cells that were largely 
devoid of lipid. Thus, the rapid restoration of fat mass following acute leptin 
deficiency does not appear to require new fat cell production. Several additional 
lines of evidence support this conclusion. First, mitoses were not visible in tissue 
sections from adipose tissue after leptin withdrawal during times when adipose 
mass is being rapidly repleted. Second, as assessed using the data from the 
transcriptional profiles, genes known to induce terminal differentiation of 
adipocytes or that are involved in the clonal expansion phases of adipogenesis in 
vitro (Gutman and Shafrir, 1964) remained unchanged or decreased in 
abundance during acute leptin deficiency. In addition, previous studies have 
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reported that adipose tissue from animals treated with leptin contains the same 
DNA content as control samples (Zhou et al., 1999). Therefore, it was concluded 
that the restoration of fat mass is the result of the activation of a program of lipid 
re-accumulation in lipid-depleted adipocytes and does not appear to be 
associated with de-novo adipogenesis. 
The re-accumulation of fat mass following weight loss is the result of the 
activation of a novel gene expression program that is activated by acute 
hypoleptinemia. The initial phase of this cellular program is marked by an 
increase in adipocyte glycogen content. The glycogen content of white adipose 
tissue is normally exceedingly low (Cahill et al., 1959) and previous studies have 
shown that fasting reduces glycogen levels even further while subsequent 
refeeding transiently increases adipose tissue glycogen content (Gutman and 
Shafrir, 1964; Rose and Shapiro, 1955; Tuerkischer and Wertheimer, 1942). The 
stimulus for this response was not previously known. This data indicates that low 
leptin levels provide this stimulus, such as those present with refeeding after a 
period of food restriction or after leptin withdrawal. Furthermore, the studies of 
animals experiencing leptin withdrawal in the context of restrained food intake 
(Leptin-NC animals) further indicated that the observed increase in glycogen 
synthesis in white adipose tissue after refeeding was not the result of 
hyperinsulinemia (Kaslow and Mayer, 1979). 
The increased pool of glycogen in white adipose tissue during fat 
regeneration appears to provide the substrate for expansion of adipose 
triglyceride mass. This conclusion is consistent with previous findings showing 
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that adipose triglyceride stores are primarily synthesized within adipose tissue 
and rather than being imported into fat cells after being synthesized elsewhere 
(Rose and Shapiro, 1955). Glycogen-containing adipose tissue from animals 
refed after a 48 hour fast was previously shown to have a respiratory quotient of 
greater than 1.0 indicative of a high rate of glucose metabolism and not fatty 
acids (Tuerkischer and Wertheimer, 1942; Wertheimer, 1945). In re-fed animals, 
glycogen disappears from adipose tissue at the same time as fatty acid synthesis 
is at its maximum and PAS positive material and lipid droplets can be easily seen 
in the same cells during the recovery from weight loss (Rose and Shapiro, 1955). 
Finally, glycogen is an efficient precursor of both components of adipose tissue 
triglycerides, the fatty acid and glycerol moieties (Gutman and Shafrir, 1964). In 
aggregate, these data suggest that the re-accumulation of fat mass following 
withdrawal of leptin treatment or refeeding following a fast involves 1) the 
increased glycogen synthesis which is likely to be substrate driven as mRNAs for 
the genes involved in glycogen synthesis and breakdown do not fall during leptin 
treatment or subsequent withdrawal, and 2) transcriptional induction of genes 
required for lipid biosynthesis from monosaccharides.  
Lipid stores in the adipocytes may arise from two major routes: de novo 
lipogenesis from non-lipid precursors or uptake of fatty acids from plasma. In this 
study, it is suggested that lipid repletion, at least following leptin treatment, may 
be through a de novo lipogenic pathway involving a glycogen intermediate and 
upregulation of transcriptional pathways. Adipose tissue, liver and mammary 
glands (lactation) were before shown to be sites for de novo lipogenesis in 
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mammals (Blouin et al., 2009; Lafontan, 2008). De novo lipogenesis has been 
found to be active when small animals are fed on carbohydrate rich and low fat 
diet (Blouin et al., 2009; Lafontan, 2008).   Another major route for triglyceride 
deposition in adipose tissue is through the uptake of pre-existing fatty acids from 
circulating triglycerides in form of chylomicrons/VLDL particles. It is still 
controversial which of the lipogenic mechanisms is the major pathway for 
adipose tissue lipid accumulation. It is possible that both pathways take place to 
certain extents in different metabolic conditions. Note, it is also suggested by 
several studies that the contribution of adipose tissue to the whole body 
lipogenesis is relatively lower in humans. A comparison of lipogenesis in the 
adipose tissue of humans confirmed that the capacity of lipogenic pathways of 
adipose tissue is less in humans, possibly due to the lower abundance of the 
transcription factors controlling the lipogenic pathways, namely SREBP-1 and 
CHREBP (Letexier et al., 2003). 
The failure of the mRNAs involved in glycogen metabolism to change after 
fasting or leptin treatment is in contrast to the enzymes of glycolysis and the 
enzymatic cascade necessary to generate acetyl-CoA from simple sugars, which 
are clearly induced under these conditions. In previous studies these genes have 
been reported to be regulated predominantly by post-transcriptional mechanisms 
(Daran-Lapujade et al., 2004; Daran-Lapujade et al., 2007). Thus, the response 
to leptin withdrawal or refeeding is not simply an induction of the same genes 
repressed during leptin treatment and instead constitutes a novel program for 
adipocyte gene expression. The transcriptional mechanism responsible for the 
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upregulation of this functionally linked group of genes is not known and future 
studies of the factors that regulate this program may provide new avenues for 













CHAPTER 8:  
Conclusion 
Summary of findings 
 Adipose biology field has long been driven by the in vitro models due to 
the ease and availability of the cell lines that were discovered by Green and 
colleagues. There is now evidence that the in vitro adipogenic processes do in 
fact reflect in vivo events only partially. This urges the need to study adipocytes 
in vivo. Major problems to study adipogenic processes in vivo are lack of 
markers, poorly characterized in vivo animal models and unknown identity of the 
adipogenic cell types. The development of new markers and characterization 
studies on the adipocyte development in vivo will help to solve these problems.  
 The primary goal of this thesis has been to characterize the molecular and 
cellular events in white adipose tissue in vivo. Firstly, an early transcriptional 
network has been discovered including KLF4 and Krox20 as essential early 
regulators of adipogenesis. Klf4 is expressed in 3T3-L1 cells within 30 min after 
exposure to a standard adipogenic cocktail of insulin, glucocorticoids, and IBMX. 
Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPβ levels. 
KLF4 binds directly to the C/EBPβ (C/EBPβ) promoter as shown by chromatin 
immunoprecipitation and gel shift assays and, together with Krox20, 
cooperatively transactivates a C/EBPβ reporter. C/EBPβ knockdown increases 
levels of KLF4 and Krox20, suggesting that C/EBPβ normally suppresses Krox20 
and KLF4 expression via a tightly controlled negative feedback loop. KLF4 is 
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specifically induced in response to cAMP, which by itself can partially activate 
adipogenesis. These data suggest that KLF4 functions as an immediate early 
regulator of adipogenesis to induce C/EBPβ. 
 Secondly, we characterized an early adipocyte progenitor cell population 
which can reconstitute functional adipose in lipodystrophic animals. Use and 
characterization of lipodystrophic animals was crucial for this result, because 
transplantation studies using wild type animals do not result in any new functional 
adipocytes, which is probably due to the quiescent state of the wild type adipose 
as assessed by many other studies. A-ZIP lipodystrophic animals, however, were 
found to be hyperadipogenic- as evaluated by the upregulation of early 
transcription factors, KLF4, Krox20 and Pref1 that were previously identified and 
hyperproliferative- as determined by BrdU incorporation studies. One other 
model that helped the identification of adipocyte progenitor cells was leptin-
luciferase BAC transgenic animals. Leptin-luciferase transgenic mouse 
expresses the luciferase reporter gene under the control of leptin regulatory 
sequences, which allows noninvasive imaging of the leptin expression of 
adipocytes in vivo. Cell sorting studies identified a subpopulation of early 
adipocyte progenitor cells (Lin :CD29+:CD34+:Sca-1+:CD24+) resident in adult 
WAT. When injected into the residual fat pads of A-Zip lipodystrophic mice, these 
cells, sorted from leptin-luciferase animals, reconstituted a normal WAT depot 
and rescued the diabetic phenotype that developed in these animals. The 
development of adipose was determined using a CCD camera, since luciferase is 
expressed only in mature adipocytes. This study provides the identification of an 
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undifferentiated adipocyte precursor subpopulation resident within the adipose 
tissue stroma that is capable of proliferating and differentiating into an adipose 
depot in vivo.  
 Adipocyte differentiation possibly is most active in the 
embryonic/postembryonic stages of life, and adipocytes increase their size 
(hypertrophy) greatly as soon as energy intake starts. However, there is no 
descriptive study on adipose tissue development in rodents up to this date. This 
led us to characterize mouse adipose tissue development. One caveat to study 
adipose tissue development is that the adipocyte markers are thought to be 
expressed after the accumulation of lipids according to in vitro data. However, it 
is very likely that the adipocyte character and commitment occurs before the 
accumulation of lipids. In this regard, lipid itself cannot be used to localize where 
adipose tissue develops. Leptin-luciferase animals proved to be useful in this 
regard. Even though luciferase expression was extremely low in these animals, it 
was still detectable, making it possible to dissect and study the developing fat. 
These studies showed that fat starts to accumulate after birth. More interestingly, 
many of the adipocyte transcription factors/markers such as ap2, adipsin, 
adiponectin, PPARƔ and C/EBPα that were thought to be expressed after fat 
accumulation were actually found to be expressed high levels much earlier than 
the accumulation of fat. This result was contradictory to 3T3-L1 studies, where 
these genes are expressed after accumulation of lipid.  It implies that 
adipogenesis in vitro does not exactly reflect the in vivo processes. This result in 
a way shows the need for the field to move to in vivo systems. 
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 As explained above, in vivo and in vitro adipogenic processes are 
probably different. One other example to this phenomenon is the expression of 
leptin gene. Leptin expression is ~100 times lower in in vitro differentiated 
adipocyte cell lines compared to tissue levels (Hwang et al., 1997; Mandrup and 
Lane, 1997; Mandrup et al., 1997a). Surprisingly, these adipocyte cell lines 
abundantly express the master regulator PPARƔ, C/EBPs and their targets 
(Hwang et al., 1997). This supports that the adipocyte-specific expression of 
leptin is controlled by a different transcriptional mechanism than the conventional 
adipocyte regulators. Studying leptin gene expression will give more insights 
about adipocyte specific transcriptional networks. Moreover, leptin is secreted in 
proportion to adipose tissue mass and in turn regulates food intake and energy 
expenditure. Adipocytes secrete leptin in proportion to their size meaning that as 
they accumulate more lipids, they secrete more leptin. This suggests the 
possibility that cellular lipid content is sensed and that a fuller understanding of 
the mechanisms controlling leptin gene expression could also lead to the 
delineation of a lipid sensing mechanism in fat cells and possibly other cell types. 
To discover this mechanism, we searched for the region in the leptin gene 
promoter that controls the quantitative expression of the leptin gene; ie the 
elements that confer increased leptin expression with obesity and decreased 
expression after weight loss. Since leptin is expressed at much higher levels in 
fat tissue in vivo than in vitro where it is not regulated in proportion to cellular lipid 
content, these studies require that gene expression be monitored in vivo. We 
thus generated a deletion series of BAC transgenic mouse lines that express 
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luciferase under the control of overlapping leptin regulatory sequences. We 
already have evidence that the cis element that confers qualitative and 
quantitative control of the leptin gene is located between – 762bp and +8kb 
relative to the transcription start site. This result suggests that leptin expression is 
more complex than it was thought before.  
 As explained above, leptin mRNA levels are highly correlated with adipose 
tissue mass, and leptin expression can thus be used as a surrogate for changes 
in the amount of adipose tissue. Since luciferase is expressed by leptin 
regulatory sequences in leptin-luciferase animals, which allows noninvasive 
imaging of the leptin expression of mice in vivo, luciferase signal can be used to 
track the lipid accumulation. Here leptin-luciferase mice were used to show that 
weight loss induced by fasting or leptin treatment results in the retention of lipid-
depleted adipocytes in adipose depots. To further study the cellular response to 
weight regain after leptin treatment, a leptin withdrawal protocol was used to 
induce a state of acute leptin deficiency in wild type mice. Acute leptin deficiency 
led to the transient deposition of large amounts of glycogen within pre-existing, 
lipid-depleted adipocytes. This was followed by rapid reaccumulation of lipid. 
Transcriptional profiling revealed that this cellular response was associated with 
induction of mRNAs for the entire pathway of enzymes necessary to convert 





Future Directions and Concluding Remarks 
 The advent of DNA chip technology made it possible to analyze a plethora 
of genes across different experimental conditions or follow gene expression 
patterns through a time course. In this thesis, KLF4 and Krox20 were discovered 
through a comparison between in vitro differentiated adipocytes versus in vivo 
adipose tissue. The fact that there are earlier factors in 3T3-L1 differentiation 
suggests that there may actually be more genes upregulated very early in 
adipogenesis. These earlier genes may be discovered by an earlier time course 
microarray analysis of 3T3-L1 differentiation. Identification of these factors may 
give rise to broader analysis of early regulation of adipogenesis. 
 One caveat of studying earlier factors in adipogenesis is that the role of 
several genes expressed early during development such as Krox20, KLF4 and 
C/EBPβ cannot be studied in fat specific knockout mice because ap2-cre and 
other drivers such adiponectin are expressed late in the course of differentiation 
and would thus knock out these early genes at a point in time after their 
expression is required. Furthermore, often times germ line and adipocyte specific 
knockouts are uninterpretable when adipocyte genes are expressed in other 
tissues in adults or during development. For this reason, either earlier markers 
should be identified or another technique should be devised. Identification of 
earlier markers is relatively difficult, because many genes that have roles in 
differentiation of adipogenesis do also have roles in other differentiation 
processes. To address this, an ES complementation approach can be 
developed.  This approach depends on the ability of ES cells to reconstitute the 
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germ line when injected into blastocysts A/ZIP transgenic animals. Since A/ZIP 
lipodystrophic animals do not have any fat tissue, all the fat in the chimeric 
animals comes from ES cells.  This approach can be employed to study the role 
of specific genes during adipocyte development or on adipocyte function.  For 
example, the function of adipose genes by introducing siRNA plasmids to knock-
down the expression of specific genes into ES cells can be used to validate the 
role of three major early genes described above C/EBPβ, Krox20 and Klf4.  
Preliminary experiments demonstrated that microinjection of wild-type embryonic 
stem (ES) cells into lipodystrophic blastocysts produces chimeras that are 
positive for the A/ZIP transgene but which have a normal adipose tissue mass 
and normal blood glucose.  This is demonstrated directly by the fact that in 
adipose tissue from these chimaeras, all of the adipocytes express YFP while in 
other tissues there is a variable contribution from the ES cells such that fat tissue 
is 100% YFP positive while liver and other tissues are not.  Since the original 
lipodystrophic background cells are incapable of making ES cells due to the 
expression of dominant negative transcription factor against B-ZIPs, this shows 
that all of the adipocytes are derived from the wild type ES cells.  These 
preliminary results indicate that indeed an ES cell complementation strategy may 
provide the tool to study adipogenesis in vivo. 
 Adipocyte progenitor cells can also be useful to study adipocyte 
development in vivo. Since it was shown that CD24+CD34+ cell population can 
differentiate into adipocytes in vivo, these cells can now be modified by 
lentiviruses carrying siRNA/plasmids and transplanted into A/ZIP fat pads.  This 
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system will be extremely fast and cost–effective. It should be noted that it is still 
not known how many different cell populations or differentiation stages there are 
in adipogenesis. It is possible that adipocyte differentiation occurs through 
different stages as it is for hematopoiesis. It is also not known if there are several 
different cell types for forming different adipocytes such as the ones in 
subcutaneous/ visceral or bone marrow adipocytes. Heterogeneity in adipose 
tissue is an area that is poorly studied. It can be speculated that there can even 
be different progenitor cells for different adipose types. If this is true, it is possible 
to find different progenitors using same scheme but different cell sorting markers.  
 Leptin gene expression studies in this thesis sets up a starting point for 
further studies. Up to this date, sequences regulating fat specificity and high 
expression were confined between -762bp and +8kb, which spans the first intron. 
Surprisingly, 762bp upstream sequence itself is not enough to confer fat 
specificity and 22kb upstream sequence is enough to confer fat specificity. This 
result suggests a redundancy for leptin expression. It is also possible that 762 bp 
fragment is enough to confer fat specificity but is only effective with the enhancer 
from either upstream or downstream. In either case, these studies will help for 
further studies to identify the cis-elements that regulate leptin.Once the promoter 
region(s) is localized to less than 1kB region, gel shift experiments can be 
performed with nested ~ 50-100 bp fragments across the region using nuclear 
extracts from ob, fed and fasted adipose tissue.  With this information in hand, it 
is straightforward to perform DNAse foot printing to map the precise binding site.  
This sequence can then be used as an affinity probe to facilitate the biochemical 
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purification of the differentially expressed transcription factor.  This could 
potentially allow working back to a putative lipid sensing mechanism.  
 One other approach to find possible trans factors and mechanisms that 
regulate leptin expression is by using microarray analysis. Leptin expression is 
upregulated in obese/high fat fed animals and downregulated in fasted animals. 
Furthermore, leptin is adipocyte-specific such that when the adipose tissue is 
dissociated by collagenase digestion, the pelleted stromavascular fraction does 
not have any detectable leptin mRNA compared to adipocytes. In addition, leptin 
treatment of obese animals causes a time-dependent decrease in leptin gene 
expression.  During development, leptin is reported to be upregulated postnatal 
day 8-10 -also known as the leptin surge (Ahima and Flier, 2000). In addition, 
time course microarray analysis of adipose tissue development show that leptin 
expression increase as lipid accumulates after P0. All these different conditions 
can provide as tools to find transcription factors that correlate with leptin gene 
expression. 
The identification of molecular and cellular pathways regulating adipocyte 
development and regulation in vivo will have implications for basic and clinical 
understanding of obesity. Furthermore, the availability of systems such as the 
leptin-luciferase mice and hyperadipogenic A-Zip lipodystrophic animals will help 
to identify new cell populations and give the way to characterize in vivo 
adipogenesis. Overall, these approaches will provide a means to study the 
potential of cells from various sources to form WAT and creates new possibilities 
for the determination of the roles that individual factors play in the control and 
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